@prefix ns1: <http://hl7.org/fhir/> .
@prefix ns2: <http://example.com/> .

ns2:AcquiredArterialLesions a ns1:Condition ;
    ns1:name "Acquired arterial lesions" .

ns2:AcuteAntihypertensiveTherapy a ns1:Procedure ;
    ns1:context "only in certain circumstances" ;
    ns1:name "Acute antihypertensive therapy" ;
    ns1:subject ns2:IschemicStroke .

ns2:AcuteIschemicStroke a ns1:Condition ;
    ns1:value "Acute ischemic stroke" .

ns2:AcuteMeningitis a ns1:Condition ;
    ns1:code [ a ns1:CodeableConcept ;
            ns1:coding [ a ns1:Coding ;
                    ns1:code "822031000000101" ;
                    ns1:display "Acute Meningitis" ;
                    ns1:system "http://snomed.info/sct" ] ] ;
    ns1:relatedTo ns2:VascularInflammation .

ns2:AcuteStrokeTreatment a ns1:Procedure ;
    ns1:guideline ns2:GuidelinesForEarlyManagement ;
    ns1:recommendedBy ns2:AmericanHeartAssociation,
        ns2:AmericanStrokeAssociation ;
    ns1:requires ns2:Hospitalization,
        ns2:SupportiveMeasures .

ns2:Alfimeprase a ns1:MedicationRequest .

ns2:AmphetamineUse a ns1:Condition ;
    ns1:relatedTo ns2:SympathomimeticDrugUse ;
    ns1:value "Amphetamine Use" .

ns2:Anticoagulation a ns1:Procedure ;
    ns1:context "sometimes" ;
    ns1:name "Anticoagulation" ;
    ns1:subject ns2:IschemicStroke .

ns2:AnticoagulationHeparin a ns1:Medication ;
    ns1:description "Anticoagulation with heparin" ;
    ns1:purpose "reduce the risk of recurrent cardiac emboli" ;
    ns1:use "stroke caused by cerebral venous thrombosis and sometimes for stroke caused by cervical artery dissection" .

ns2:AnticoagulationLowMolecularWeightHeparin a ns1:Medication ;
    ns1:description "Anticoagulation with low molecular weight heparin" ;
    ns1:purpose "reduce the risk of recurrent cardiac emboli" ;
    ns1:use "stroke caused by cerebral venous thrombosis and sometimes for stroke caused by cervical artery dissection" .

ns2:AntinuclearAntibodies a ns1:Observation ;
    ns1:description "Antinuclear antibodies" ;
    ns1:partOf ns2:RheumaticDisordersTesting .

ns2:AntiphospholipidAntibodies a ns1:Observation ;
    ns1:description "Antiphospholipid antibodies" ;
    ns1:partOf ns2:ThromboticDisordersTesting .

ns2:AntiplateletMedication a ns1:Medication ;
    ns1:combinationEfficacy "Not established" ;
    ns1:combinationSafety "Not established" ;
    ns1:combinationWith ns2:NewAnticoagulants .

ns2:AntithrombinIII a ns1:Observation ;
    ns1:code [ a ns1:CodeableConcept ;
            ns1:coding [ a ns1:Coding ;
                    ns1:code "34086003" ;
                    ns1:display "Antithrombin III" ;
                    ns1:system "http://snomed.info/sct" ] ] ;
    ns1:partOf ns2:ThromboticDisordersTesting .

ns2:Aspirin a ns1:Medication ;
    ns1:Medication.dosage "81 or 325 mg once a day" ;
    ns1:code [ a ns1:CodeableConcept ;
            ns1:coding [ a ns1:Coding ;
                    ns1:code "387458008" ;
                    ns1:display "Aspirin" ;
                    ns1:system "http://snomed.info/sct" ] ] ;
    ns1:dosage "325 mg orally",
        "81 to 325 mg within 48 hours of stroke onset" ;
    ns1:purpose "reduce the risk of early recurrent stroke and death" ;
    ns1:relatedTo ns2:AntiplateletMedications ;
    ns1:use "acute stroke treatment" .

ns2:Atherosclerosis a ns1:Condition ;
    ns1:description "Atherosclerosis" .

ns2:AtheroscleroticStroke a ns1:Condition ;
    ns1:description "evidence of atherosclerotic stroke" .

ns2:Atorvastatin a ns1:Medication ;
    ns1:description "80 mg once a day is recommended for patients with evidence of atherosclerotic stroke and LDL cholesterol ≥ 100 mg/dL." ;
    ns1:dosage "80 mg" ;
    ns1:frequency "once a day" .

ns2:BPReduction a ns1:Procedure ;
    ns1:description "BP Reduction" ;
    ns1:relatedTo ns2:IschemicStroke .

ns2:BloodRiskFactors a ns1:Observation ;
    ns1:component [ ns1:code "Diabetes",
                "Dyslipidemia",
                "Hypercoagulability" ] ;
    ns1:description "Blood Risk Factors" .

ns2:BridgingTherapy a ns1:Procedure ;
    ns1:description "Bridging therapy" .

ns2:CYP2C19 a ns1:Observation ;
    ns1:Observation.description "CYP2C19" ;
    ns1:Observation.statement "a test to determine CYP2C19 status (eg, genetic testing for CYP450 polymorphisms) is recommended",
        "if impaired metabolism is confirmed, aspirin or combination aspirin and ticagrelor is a reasonable alternative" .

ns2:CaliberOfCollateralVessels a ns1:Condition ;
    ns1:description "Caliber of various collateral vessels" .

ns2:CardiacEmboli a ns1:Condition ;
    ns1:description "Cardiac emboli" ;
    ns1:purpose "reduce the risk of recurrent cardiac emboli" ;
    ns1:use "anticoagulation treatment" .

ns2:CardiacRiskFactors a ns1:Observation ;
    ns1:component [ ns1:code "Atrial fibrillation",
                "Potential structural sources of emboli" ] ;
    ns1:description "Cardiac Risk Factors" .

ns2:CarotidArtery a ns1:AnatomicalStructure ;
    ns1:name "Carotid artery" ;
    ns1:partOf ns2:EfficientCollateralSystem .

ns2:CarotidStenting a ns1:Procedure ;
    ns1:complication ns2:RecurrentStroke ;
    ns1:device ns2:EmboliProtectionDevice ;
    ns1:indication ns2:CarotidObstruction,
        ns2:HighSurgicalRisk,
        ns2:RecentNondisablingSubmaximalStroke,
        ns2:UlceratedPlaque ;
    ns1:outcome ns2:StrokePrevention ;
    ns1:performedBy ns2:Interventionists,
        ns2:Surgeons ;
    ns1:preferredFor ns2:HighSurgicalRiskPatients,
        ns2:PatientsOver70Years .

ns2:CarotidUltrasonography a ns1:Procedure ;
    ns1:description "Carotid ultrasonography" ;
    ns1:partOf ns2:Testing ;
    ns1:relatedTo ns2:AnteriorCirculation .

ns2:CerebralVenousThrombosis a ns1:Condition ;
    ns1:description "Cerebral venous thrombosis" ;
    ns1:purpose "reduce the risk of recurrent cardiac emboli" ;
    ns1:use "anticoagulation treatment" .

ns2:CervicalArteryDissection a ns1:Condition ;
    ns1:description "Cervical artery dissection" ;
    ns1:purpose "reduce the risk of recurrent cardiac emboli" ;
    ns1:use "anticoagulation treatment" .

ns2:ChronicMeningitis a ns1:Condition ;
    ns1:code [ a ns1:CodeableConcept ;
            ns1:coding [ a ns1:Coding ;
                    ns1:code "21664006" ;
                    ns1:display "Chronic Meningitis" ;
                    ns1:system "http://snomed.info/sct" ] ] ;
    ns1:relatedTo ns2:VascularInflammation .

ns2:Clevidipine a ns1:Medication ;
    ns1:dosage "1 to 2 mg/hour IV infusion (titrate by doubling the dose every 2 to 5 minutes until desired BP is reached to a maximum of 21 mg/hour)" ;
    ns1:relatedTo ns2:BP .

ns2:ClinicalFindings a ns1:Observation ;
    ns1:name "Clinical findings" .

ns2:Clinician a ns1:Practitioner ;
    ns1:role "Clinician" .

ns2:Clopidogrel a ns1:Medication ;
    ns1:Medication.dosage "75 mg once a day" ;
    ns1:Medication.indication "for patients who are allergic to aspirin" ;
    ns1:Medication.statement "if ischemic stroke recurs or if a coronary artery stent becomes blocked while patients are taking clopidogrel, clinicians should suspect impaired metabolism of clopidogrel",
        "if patients cannot tolerate clopidogrel or have clopidogrel resistance due to CYP2C19 loss of allele, ticagrelor 90 mg twice a day can be substituted" ;
    ns1:code [ a ns1:CodeableConcept ;
            ns1:coding [ a ns1:Coding ;
                    ns1:code "386952008" ;
                    ns1:display "Clopidogrel" ;
                    ns1:system "http://snomed.info/sct" ] ] ;
    ns1:purpose "reduce the risk of stroke in the first 90 days" ;
    ns1:use "acute stroke treatment" .

ns2:ClopidogrelPlusAspirin a ns1:Medication ;
    ns1:Medication.statement "before and for ≥ 30 days after stenting is indicated, usually for ≤ 6 months",
        "if started during acute treatment, is given for only a short time (eg, < 3 weeks) because it has no advantage over aspirin alone in long-term secondary stroke prevention and results in more bleeding complications" ;
    ns1:Medication.value "Clopidogrel plus aspirin" .

ns2:ClopidogrelResistance a ns1:Condition ;
    ns1:purpose "use dual antiplatelet therapy with aspirin and ticagrelor" ;
    ns1:use "patients with CYP2C19 loss of function allele" ;
    ns1:value "Clopidogrel resistance" .

ns2:CocaineUse a ns1:Condition ;
    ns1:relatedTo ns2:SympathomimeticDrugUse ;
    ns1:value "Cocaine Use" .

ns2:CombinationProduct a ns1:Medication ;
    ns1:Medication.dosage "2 times a day" ;
    ns1:Medication.value "Combination product aspirin 25 mg/extended-release dipyridamole 200 mg" .

ns2:CompleteBloodCount a ns1:Observation ;
    ns1:partOf ns2:BloodTests ;
    ns1:value "Complete blood count (CBC)" .

ns2:Contraindications a ns1:Observation ;
    ns1:description "Contraindications" ;
    ns1:relatedTo ns2:AntiplateletMedications ;
    ns1:value "aspirin-induced or nonsteroidal anti-inflammatory drug (NSAID)-induced asthma or urticaria, other hypersensitivity to aspirin or to tartrazine, acute gastrointestinal bleeding, glucose-6-phosphate dehydrogenase (G6PD) deficiency, and use of warfarin" .

ns2:ConventionalAngiography a ns1:Procedure ;
    ns1:partOf ns2:Testing ;
    ns1:value "Conventional angiography" .

ns2:Cost a ns1:Observation ;
    ns1:disadvantage ns2:NewAnticoagulants .

ns2:DAWNTrial a ns1:ResearchStudy ;
    ns1:name "DAWN trial" ;
    ns1:outcome ns2:LargeMismatchBetweenInfarctVolumeAndClinicalDeficit,
        ns2:SymptomOnset24Hours .

ns2:DEFUSE3Trial a ns1:ResearchStudy ;
    ns1:name "DEFUSE 3 trial" ;
    ns1:outcome ns2:LargerPenumbra,
        ns2:SmallInfarct,
        ns2:SymptomOnset16Hours .

ns2:Damage a ns1:Condition ;
    ns1:causedBy ns2:BrainIschemia ;
    ns1:name "Damage" .

ns2:DiagnosisOfIschemicStroke a ns1:Condition ;
    ns1:clinicalStatus "active" ;
    ns1:method ns2:BedsideGlucoseTesting,
        ns2:ClinicalEvaluation,
        ns2:Neuroimaging ;
    ns1:name "Diagnosis of Ischemic Stroke" ;
    ns1:note "Evaluation to identify the cause" ;
    ns1:verificationStatus "confirmed" .

ns2:DiagnosticEvaluation a ns1:Procedure ;
    ns1:definition "The diagnostic evaluation is incomplete." ;
    ns1:name "Diagnostic evaluation" .

ns2:DiffusionWeightedImaging a ns1:Procedure ;
    ns1:name "Diffusion-weighted imaging" .

ns2:DissectionOfAorta a ns1:Condition ;
    ns1:name "Dissection of Aorta" ;
    ns1:relatedTo ns2:Stroke .

ns2:DissectionOfIntracranialArteries a ns1:Condition ;
    ns1:name "Dissection of Intracranial Arteries" ;
    ns1:relatedTo ns2:Stroke .

ns2:DistalA2 a ns1:AnatomicalLocation ;
    ns1:description "anterior cerebral artery distal to the anterior communicating artery" ;
    ns1:name "Distal A2" .

ns2:DualAntiplateletTherapyAspirinClopidogrel a ns1:Medication ;
    ns1:dosage "300 to 600 mg orally once, then 75 mg orally once a day within 24 hours of stroke onset" ;
    ns1:name "Dual antiplatelet therapy with aspirin plus clopidogrel" ;
    ns1:purpose "reduce the risk of stroke in the first 90 days" ;
    ns1:use "patients with minor stroke or at high risk of a transient ischemic attack (TIA; ABCD2 score ≥ 4)" .

ns2:DualAntiplateletTherapyAspirinTicagrelor a ns1:Medication ;
    ns1:dosage "loading dose of 180 mg on day 1 followed by 90 mg twice a day" ;
    ns1:name "Dual antiplatelet therapy with aspirin and ticagrelor" ;
    ns1:purpose "reduce the risk of stroke in the first 90 days" ;
    ns1:use "patients with clopidogrel resistance CYP2C19 loss of function allele, especially if an extracranial or intracranial stent is used" .

ns2:ECG a ns1:Procedure ;
    ns1:name "ECG" ;
    ns1:reasonReference ns2:CardiacCauses .

ns2:EaseOfUse a ns1:Observation ;
    ns1:advantage ns2:NewAnticoagulants ;
    ns1:description "No need to check anticoagulation level with a blood test after the initial dose or to use a parenteral anticoagulant such as unfractionated heparin given by continuous infusion when transitioning from parenteral to oral anticoagulants" .

ns2:Edoxaban a ns1:MedicationRequest ;
    ns1:dosageInstruction [ a ns1:Dosage ;
            ns2:form "Tablet" ;
            ns2:route "Oral" ;
            ns2:strength "20.210 mg" ],
        [ a ns1:Dosage ;
            ns2:form "Tablet, coated" ;
            ns2:route "Oral" ;
            ns2:strength "15 mg" ],
        [ a ns1:Dosage ;
            ns2:form "Tablet" ;
            ns2:route "Oral" ;
            ns2:strength "60 mg" ],
        [ a ns1:Dosage ;
            ns2:form "Tablet, film coated" ;
            ns2:route "Oral" ;
            ns2:strength "30 mg" ] .

ns2:Embolus a ns1:Condition ;
    ns1:code [ a ns1:CodeableConcept ;
            ns1:coding [ a ns1:Coding ;
                    ns1:code "55584005" ;
                    ns1:display "Embolus" ;
                    ns1:system "http://snomed.info/sct" ] ] .

ns2:Endarterectomy a ns1:Procedure ;
    ns1:code [ a ns1:CodeableConcept ;
            ns1:coding [ a ns1:Coding ;
                    ns1:code "392031002" ;
                    ns1:display "Endarterectomy" ;
                    ns1:system "http://snomed.info/sct" ] ] ;
    ns1:relatedTo ns2:IschemicStroke .

ns2:EndovascularClosureOfPatentForamenOvale a ns1:Procedure ;
    ns1:effectiveTime "< 60 years" ;
    ns1:indication ns2:EmbolicStrokeOfUndeterminedCause ;
    ns1:recommendation ns2:AntiplateletTherapy .

ns2:EpiduralHematoma a ns1:Condition ;
    ns1:code [ a ns1:CodeableConcept ;
            ns1:coding [ a ns1:Coding ;
                    ns1:code "703861005" ;
                    ns1:display "Epidural Hematoma" ;
                    ns1:system "http://snomed.info/sct" ] ] ;
    ns1:excludedBy ns2:Neuroimaging .

ns2:ErythrocyteSedimentationRate a ns1:Observation ;
    ns1:name "Erythrocyte sedimentation rate" ;
    ns1:partOf ns2:RheumaticDisordersTesting .

ns2:ExtracranialCarotidEndarterectomy a ns1:Procedure ;
    ns1:complication ns2:MyocardialInfarction ;
    ns1:indication ns2:CarotidObstruction,
        ns2:RecentNondisablingSubmaximalStroke,
        ns2:UlceratedPlaque ;
    ns1:outcome ns2:StrokePrevention ;
    ns1:performedBy ns2:Interventionists,
        ns2:Surgeons .

ns2:ExtracranialVertebralAngioplastyAndStenting a ns1:Procedure ;
    ns1:effectiveTime "50 to 99%" ;
    ns1:indication ns2:RecurrentSymptomsOfVertebrobasilarIschemia,
        ns2:VertebralArteryObstruction .

ns2:FactorVLeiden a ns1:Observation ;
    ns1:name "Factor V Leiden" ;
    ns1:partOf ns2:ThromboticDisordersTesting .

ns2:FastingBloodGlucose a ns1:Observation ;
    ns1:name "Fasting blood glucose" ;
    ns1:partOf ns2:BloodTests .

ns2:GeneralStrokeTreatments a ns1:Procedure ;
    ns1:name "General stroke treatments" ;
    ns1:subject ns2:IschemicStroke .

ns2:GlucoseTesting a ns1:Procedure ;
    ns1:name "Bedside glucose testing" .

ns2:HemoglobinA1C a ns1:Observation ;
    ns1:name "Hemoglobin A1C" ;
    ns1:partOf ns2:BloodTests .

ns2:HemoglobinElectrophoresis a ns1:Procedure ;
    ns1:name "Hemoglobin electrophoresis" ;
    ns1:partOf ns2:BloodTests .

ns2:HemorrhagicComplication a ns1:Condition ;
    ns1:antidote ns2:AndexanetAlfa,
        ns2:Idarucizumab .

ns2:HemorrhagicStroke a ns1:Condition ;
    ns1:name "Hemorrhagic Stroke" ;
    ns1:relatedTo ns2:ComaOrStupor,
        ns2:Headache,
        ns2:Vomiting .

ns2:HemorrhagicTransformation a ns1:Condition ;
    ns1:name "Hemorrhagic transformation" ;
    ns1:purpose "risk of hemorrhage is higher, especially with large infarcts" ;
    ns1:use "acute stage of stroke" .

ns2:HolterMonitoring a ns1:Procedure ;
    ns1:name "Holter monitoring" ;
    ns1:reasonReference ns2:CardiacCauses .

ns2:HomocysteineMeasurement a ns1:Observation ;
    ns1:name "Measurement of homocysteine" ;
    ns1:partOf ns2:BloodTests .

ns2:Hypothermia a ns1:Condition ;
    ns1:code [ a ns1:CodeableConcept ;
            ns1:coding [ a ns1:Coding ;
                    ns1:code "386689009" ;
                    ns1:display "Hypothermia" ;
                    ns1:system "http://snomed.info/sct" ] ] .

ns2:IVRecombinantTPA a ns1:Procedure ;
    ns1:name "IV recombinant tPA" .

ns2:ImplantableCardiacMonitor a ns1:Device ;
    ns1:name "Implantable cardiac monitor" ;
    ns1:reasonReference ns2:CardiacCauses ;
    ns1:useContext ns2:AtrialArrhythmiasDetection .

ns2:Infarction a ns1:Condition ;
    ns1:causedBy ns2:SevereIschemia ;
    ns1:name "Infarction" .

ns2:InflammatoryMediators a ns1:Substance ;
    ns1:contributeTo ns2:Edema,
        ns2:MicrovascularThrombosis ;
    ns1:example ns2:Interleukin1Beta,
        ns2:TumorNecrosisFactorAlpha .

ns2:IntracerebralHemorrhage a ns1:Condition ;
    ns1:code [ a ns1:CodeableConcept ;
            ns1:coding [ a ns1:Coding ;
                    ns1:code "274100004" ;
                    ns1:display "Intracerebral Hemorrhage" ;
                    ns1:system "http://snomed.info/sct" ] ] ;
    ns1:excludedBy ns2:Neuroimaging .

ns2:IntracranialMajorArteryAngioplastyAndStenting a ns1:Procedure ;
    ns1:consideration ns2:InterventionistsExperience,
        ns2:PatientCharacteristics,
        ns2:TimingOfProcedure ;
    ns1:indication ns2:OptimalTreatmentWithMedicationsIneffective ;
    ns1:outcome ns2:LowRateOfPeriproceduralAdverseEvents .

ns2:IpsilateralCarotidStenosis a ns1:Condition ;
    ns1:name "Ipsilateral carotid stenosis" .

ns2:IschemicInjury a ns1:Condition ;
    ns1:mechanism ns2:Edema,
        ns2:InfarctionWithCellNecrosis,
        ns2:MicrovascularThrombosis,
        ns2:ProgrammedCellDeath .

ns2:LDL a ns1:Observation ;
    ns1:name "low-density lipoprotein cholesterol" ;
    ns1:target "50% reduction or a level of < 70 mg/dL" ;
    ns1:value "≥ 100 mg/dL" .

ns2:Labetalol a ns1:Medication ;
    ns1:dosage "10 to 20 mg IV bolus over 1 to 2 minutes (may repeat 1 time)" ;
    ns1:relatedTo ns2:BP .

ns2:LacunarInfarct a ns1:Condition ;
    ns1:name "Lacunar infarct" ;
    ns1:subClassOf ns2:SmallInfarct .

ns2:LargeVesselOcclusion a ns1:Condition ;
    ns1:location "anterior circulation" ;
    ns1:name "Large-vessel occlusion" .

ns2:LipidProfile a ns1:Observation ;
    ns1:name "Lipid profile" ;
    ns1:partOf ns2:BloodTests .

ns2:LongTermControlOfRiskFactors a ns1:Procedure ;
    ns1:name "Long-term control of risk factors" ;
    ns1:subject ns2:IschemicStroke .

ns2:LongTermStrokeTreatment a ns1:Procedure ;
    ns1:Procedure.supportingInformation ns2:LongTermManagement,
        ns2:SupportiveCare .

ns2:MajorArteries a ns1:AnatomicalStructure ;
    ns1:name "Major arteries" ;
    ns1:partOf ns2:CerebralHemispheres .

ns2:MechanicalProstheticCardiacValve a ns1:Device ;
    ns1:targetINR "2.5 to 3.5" .

ns2:MetabolicPanel a ns1:Observation ;
    ns1:name "Metabolic panel" ;
    ns1:partOf ns2:BloodTests .

ns2:NIHSS a ns1:Observation ;
    ns1:component [ ns1:name "Language function",
                "Level of consciousness",
                "Motor deficits",
                "Sensory deficits" ] ;
    ns1:name "National Institutes of Health Stroke Scale" .

ns2:NecroticCellDeath a ns1:Condition ;
    ns1:contributingFactor ns2:ExcitatoryNeurotoxins,
        ns2:IntracellularAcidosis,
        ns2:LipidPeroxidativeDamage,
        ns2:LossOfATPStores,
        ns2:LossOfIonicHomeostasis .

ns2:Nicardipine a ns1:Medication ;
    ns1:dosage "5 mg/hour IV infusion initially (dose is increased by 2.5 mg/hour every 5 to 15 minutes to a maximum of 15 mg/hour)" ;
    ns1:relatedTo ns2:BP .

ns2:NoCauseIdentified a ns1:Observation ;
    ns1:definition "No cause is identified despite an extensive evaluation." ;
    ns1:name "No cause identified" .

ns2:NonstenoticCarotidDisease a ns1:Condition ;
    ns1:definition "Symptomatic nonstenotic carotid disease with < 50% occlusion may be an important cause of stroke." ;
    ns1:name "Nonstenotic carotid disease" .

ns2:NormalVariations a ns1:Condition ;
    ns1:bodySite ns2:CircleOfWillis ;
    ns1:name "Normal variations" .

ns2:OralAnticoagulants a ns1:Medication ;
    ns1:indication ns2:PrimaryPrevention,
        ns2:SecondaryPreventionOfCardioembolicStrokes .

ns2:OralAntiplateletMedication a ns1:Medication ;
    ns1:Medication.name "Oral antiplatelet medications" ;
    ns1:Medication.statement "used to prevent subsequent noncardioembolic (atherothrombotic, lacunar, cryptogenic) strokes (secondary prevention)" ;
    ns1:name "Oral antiplatelet medications" ;
    ns1:purpose "reduce the risk of recurrent disabling stroke" ;
    ns1:use "acute stroke treatment" .

ns2:PartialThromboplastinTime a ns1:Observation ;
    ns1:name "Partial thromboplastin time (PTT)" ;
    ns1:partOf ns2:BloodTests .

ns2:Penumbras a ns1:AnatomicalStructure ;
    ns1:name "Penumbras" ;
    ns1:partOf ns2:BrainTissue .

ns2:Perfusion a ns1:Observation ;
    ns1:name "Perfusion" ;
    ns1:relatedTo ns2:Neurons .

ns2:PerfusionCT a ns1:Procedure ;
    ns1:name "Perfusion CT" .

ns2:PerfusionMRI a ns1:Procedure ;
    ns1:name "Perfusion MRI" .

ns2:PerfusionOfIschemicBrainArea a ns1:Procedure ;
    ns1:contraindication ns2:EndOrganDamage,
        ns2:MechanicalThrombectomy,
        ns2:UseOfTPA ;
    ns1:requires ns2:HighBloodPressure .

ns2:PerfusionWeightedImaging a ns1:Procedure ;
    ns1:name "Perfusion-weighted imaging" .

ns2:Phosphocreatine a ns1:MedicationRequest ;
    ns1:dosageInstruction [ a ns1:Dosage ;
            ns2:form "Tablet" ],
        [ a ns1:Dosage ;
            ns2:form "Powder, for solution" ;
            ns2:route "Oral" ],
        [ a ns1:Dosage ;
            ns2:form "Capsule" ],
        [ a ns1:Dosage ;
            ns2:form "Injection, powder, for solution" ;
            ns2:route "Intravenous" ],
        [ a ns1:Dosage ;
            ns2:form "Injection, powder, for solution" ;
            ns2:route "Intramuscular" ],
        [ a ns1:Dosage ;
            ns2:form "Injection, powder, for solution" ;
            ns2:route "Intramuscular" ;
            ns2:strength "100 MG/ML" ],
        [ a ns1:Dosage ;
            ns2:form "Injection, powder, for solution" ;
            ns2:route "Intramuscular" ;
            ns2:strength "20 MG/ML" ] .

ns2:Pravastatin a ns1:Medication ;
    ns1:description "May be also used." .

ns2:Prevention a ns1:Procedure ;
    ns1:name "prevent recurrent strokes" ;
    ns1:target ns2:Statins .

ns2:ProbableCause a ns1:Observation ;
    ns1:definition "There is more than one probable cause (eg, atrial fibrillation and ipsilateral carotid stenosis)." ;
    ns1:value "Probable cause" .

ns2:ProteinC a ns1:Observation ;
    ns1:name "Protein C" ;
    ns1:partOf ns2:ThromboticDisordersTesting .

ns2:ProteinS a ns1:Observation ;
    ns1:name "Protein S" ;
    ns1:partOf ns2:ThromboticDisordersTesting .

ns2:ProthrombinTime a ns1:Observation ;
    ns1:name "Prothrombin time (PT)" ;
    ns1:partOf ns2:BloodTests .

ns2:Rehabilitation a ns1:Procedure ;
    ns1:code [ a ns1:CodeableConcept ;
            ns1:coding [ a ns1:Coding ;
                    ns1:code "52052004" ;
                    ns1:display "Rehabilitation" ;
                    ns1:system "http://snomed.info/sct" ] ] ;
    ns1:context "long-term treatment" ;
    ns1:subject ns2:IschemicStroke .

ns2:ReperfusionTherapy a ns1:Procedure ;
    ns1:context "acute treatment" ;
    ns1:method "recombinant tissue plasminogen activator or tenecteplase and/or mechanical thrombectomy" ;
    ns1:name "Reperfusion therapy" ;
    ns1:subject ns2:IschemicStroke .

ns2:RestoringBloodFlow a ns1:Procedure ;
    ns1:description "Restoring blood flow" ;
    ns1:relatedTo ns2:BrainIschemia .

ns2:RheumatoidFactor a ns1:Observation ;
    ns1:description "Rheumatoid factor" ;
    ns1:partOf ns2:RheumaticDisordersTesting .

ns2:Rosuvastatin a ns1:Medication ;
    ns1:description "40 mg once a day is recommended for patients with evidence of atherosclerotic stroke and LDL cholesterol ≥ 100 mg/dL." ;
    ns1:dosage "40 mg" ;
    ns1:frequency "once a day" .

ns2:SerumTroponin a ns1:Procedure ;
    ns1:name "Serum troponin" ;
    ns1:reasonReference ns2:CardiacCauses .

ns2:Simvastatin a ns1:Medication ;
    ns1:description "May be also used." .

ns2:StatinTherapy a ns1:Procedure ;
    ns1:code [ a ns1:CodeableConcept ;
            ns1:coding [ a ns1:Coding ;
                    ns1:code "315053001" ;
                    ns1:display "Statin therapy" ;
                    ns1:system "http://snomed.info/sct" ] ] ;
    ns1:relatedTo ns2:IschemicStroke .

ns2:StenoticCerebralArteries a ns1:Condition ;
    ns1:name "Stenotic Cerebral Arteries" ;
    ns1:relatedTo ns2:IschemicStroke .

ns2:StentRetrieverDevice a ns1:Device ;
    ns1:name "Stent retriever device" .

ns2:StrokeMimics a ns1:Condition ;
    ns1:name "Stroke Mimics" ;
    ns1:relatedTo ns2:NonCerebrovascularDisorders .

ns2:SubduralHematoma a ns1:Condition ;
    ns1:code [ a ns1:CodeableConcept ;
            ns1:coding [ a ns1:Coding ;
                    ns1:code "95453001" ;
                    ns1:display "Subdural hematoma" ;
                    ns1:system "http://snomed.info/sct" ] ] ;
    ns1:excludedBy ns2:Neuroimaging .

ns2:SubmaximalStroke a ns1:Condition ;
    ns1:Condition.description "A stroke is considered submaximal when after it is complete, there is residual function in the affected area, suggesting viable tissue at risk of damage" ;
    ns1:Condition.name "Submaximal Stroke" .

ns2:SuddenNeurologicDeficits a ns1:Observation ;
    ns1:name "Sudden Neurologic Deficits" ;
    ns1:relatedTo ns2:SpecificArterialTerritory .

ns2:SyphilisSerologicTesting a ns1:Procedure ;
    ns1:name "Syphilis serologic testing" ;
    ns1:partOf ns2:BloodTests .

ns2:TIAs a ns1:Condition .

ns2:Telemetry a ns1:Procedure ;
    ns1:name "Telemetry" ;
    ns1:reasonReference ns2:CardiacCauses .

ns2:Tenecteplase a ns1:Medication ;
    ns1:Medication.ingredient ns2:Alteplase,
        ns2:AminoAcids ;
    ns1:Medication.property ns2:FibrinBinding,
        ns2:PlasminogenActivatorInhibitorResistance,
        ns2:PlasminogenConversion,
        ns2:SingleBolusAdministration .

ns2:ThrombiRemovalDevices a ns1:Device ;
    ns1:name "Devices used to remove thrombi" ;
    ns1:outcome ns2:ReestablishPerfusion .

ns2:ThrombolysisInSitu a ns1:Procedure ;
    ns1:description "angiographically directed intra-arterial thrombolysis of a thrombus or embolus" ;
    ns1:example "distal A2 (anterior cerebral artery distal to the anterior communicating artery)" ;
    ns1:indication "clot too distal to be accessed by catheters" ;
    ns1:name "Thrombolysis-in-situ" ;
    ns1:relatedTo ns2:Emboli,
        ns2:Thrombi ;
    ns1:status "obsolete" .

ns2:ThrombosisOfSubclavianArtery a ns1:Condition ;
    ns1:Condition.name "Thrombosis of the subclavian artery" ;
    ns1:Condition.resultIn ns2:EmbolicStroke .

ns2:ThromboticStroke a ns1:Condition ;
    ns1:code [ a ns1:CodeableConcept ;
            ns1:coding [ a ns1:Coding ;
                    ns1:code "371040005" ;
                    ns1:display "Thrombotic stroke" ;
                    ns1:system "http://snomed.info/sct" ] ] ;
    ns1:relatedTo ns2:IschemicStroke .

ns2:Thrombus a ns1:Condition ;
    ns1:code [ a ns1:CodeableConcept ;
            ns1:coding [ a ns1:Coding ;
                    ns1:code "396339007" ;
                    ns1:display "Thrombus" ;
                    ns1:system "http://snomed.info/sct" ] ] .

ns2:Ticagrelor a ns1:Medication ;
    ns1:Medication.code [ a ns1:CodeableConcept ;
            ns1:coding [ a ns1:Coding ;
                    ns1:code "698805004" ;
                    ns1:display "Ticagrelor" ;
                    ns1:system "http://snomed.info/sct" ] ] ;
    ns1:Medication.dosage "90 mg twice a day" .

ns2:TranscranialDuplexUltrasonography a ns1:Procedure ;
    ns1:name "Transcranial duplex ultrasonography" ;
    ns1:partOf ns2:Testing .

ns2:TransesophagealEchocardiography a ns1:Procedure ;
    ns1:code [ a ns1:CodeableConcept ;
            ns1:coding [ a ns1:Coding ;
                    ns1:code "105376000" ;
                    ns1:display "Transesophageal echocardiography" ;
                    ns1:system "http://snomed.info/sct" ] ] ;
    ns1:reasonReference ns2:CardiacCauses .

ns2:TransientIschemicAttack a ns1:Condition ;
    ns1:code [ a ns1:CodeableConcept ;
            ns1:coding [ a ns1:Coding ;
                    ns1:code "266257000" ;
                    ns1:display "Transient Ischemic Attack (TIA)" ;
                    ns1:system "http://snomed.info/sct" ] ] ;
    ns1:purpose "reduce the risk of recurrent disabling stroke" ;
    ns1:use "acute stroke treatment" .

ns2:TransthoracicEchocardiography a ns1:Procedure ;
    ns1:name "Transthoracic echocardiography" ;
    ns1:reasonReference ns2:CardiacCauses .

ns2:UrgentProcedure a ns1:Procedure ;
    ns1:partOf ns2:Testing ;
    ns1:relatedTo ns2:CTAngiography,
        ns2:MagneticResonanceAngiography ;
    ns1:shouldNotDelay ns2:IVtPA ;
    ns1:value "Urgent procedure" .

ns2:Uric_acid a ns1:MedicationRequest .

ns2:UrineDrugScreen a ns1:Procedure ;
    ns1:name "Urine drug screen for cocaine and amphetamines" ;
    ns1:partOf ns2:BloodTests .

ns2:VascularImaging a ns1:Procedure ;
    ns1:name "Vascular Imaging" ;
    ns1:relatedTo ns2:ArterialStenosis .

ns2:VascularRiskFactors a ns1:Observation ;
    ns1:component [ ns1:name "Critical arterial stenosis detected by vascular imaging" ] ;
    ns1:name "Vascular Risk Factors" .

ns2:tPA a ns1:Medication ;
    ns1:relatedTo ns2:Emboli,
        ns2:Thrombi .

ns2:tPAEligibility a ns1:Procedure ;
    ns1:name "tPA Eligibility" ;
    ns1:relatedTo ns2:IschemicStroke .

ns2:AbdominalObesity a ns1:Condition ;
    ns1:name "Abdominal obesity" .

ns2:AccumulationOfLactate a ns1:Condition .

ns2:AcuteChronicMeningitis a ns1:Condition ;
    ns1:name "Acute or chronic meningitis" .

ns2:AcuteMyocardialInfarction a ns1:Condition .

ns2:AcutePericarditis a ns1:Condition .

ns2:AcuteRenalFailure a ns1:Condition .

ns2:AcuteReperfusionTherapy a ns1:Procedure ;
    ns1:reason ns2:Emboli,
        ns2:Thrombi ;
    ns1:target ns2:Patient .

ns2:AdherenceToMedicationRegimen a ns1:Observation .

ns2:AdvancedAge a ns1:Condition .

ns2:Age a ns1:Observation ;
    ns1:name "Age" .

ns2:AgeOver80 a ns1:Observation ;
    ns1:criteria "age > 80 years" .

ns2:AidInRecovery a ns1:Observation .

ns2:Air a ns1:Substance ;
    ns1:Substance.associatedWith ns2:DecompressionSickness ;
    ns1:Substance.name "Air" .

ns2:AirEmboli a ns1:Condition ;
    ns1:name "Air emboli" .

ns2:AirwaySupport a ns1:Procedure ;
    ns1:indication ns2:BulbarDysfunction,
        ns2:DecreasedConsciousness .

ns2:AlcoholUseDisorder a ns1:Condition .

ns2:Alteplase a ns1:Medication,
        ns1:MedicationRequest ;
    ns1:Medication.property ns2:BleedingRisk,
        ns2:TherapeuticWindow ;
    ns1:dosageInstruction [ a ns1:Dosage ;
            ns2:form "Solution" ;
            ns2:route "Intravenous" ;
            ns2:strength "50 MG" ],
        [ a ns1:Dosage ;
            ns2:form "Injection, powder, for solution" ;
            ns2:route "Parenteral" ],
        [ a ns1:Dosage ;
            ns2:form "Injection, powder, for solution" ;
            ns2:route "Intravenous" ;
            ns2:strength "2 MG" ],
        [ a ns1:Dosage ;
            ns2:form "Solution" ;
            ns2:route "Intravenous" ;
            ns2:strength "20 MG" ],
        [ a ns1:Dosage ;
            ns2:form "Injection, powder, lyophilized, for solution" ;
            ns2:route "Intravenous" ;
            ns2:strength "2.2 mg/2mL" ],
        [ a ns1:Dosage ;
            ns2:form "Injection, powder, for solution" ;
            ns2:route "Intravenous" ;
            ns2:strength "20 MG/20ML" ],
        [ a ns1:Dosage ;
            ns2:form "Powder" ;
            ns2:strength "50 mg/1vial" ],
        [ a ns1:Dosage ;
            ns2:form "Injection, powder, lyophilized, for solution; kit" ;
            ns2:route "Intravenous" ;
            ns2:strength "50 mg/50mL" ],
        [ a ns1:Dosage ;
            ns2:form "Powder, for solution" ;
            ns2:route "Intravenous" ],
        [ a ns1:Dosage ;
            ns2:form "Liquid; powder, for solution" ;
            ns2:route "Intravenous" ],
        [ a ns1:Dosage ;
            ns2:form "Powder, for solution" ;
            ns2:route "Intravenous" ;
            ns2:strength "2 mg / vial" ],
        [ a ns1:Dosage ;
            ns2:form "Solution" ;
            ns2:route "Intravenous" ],
        [ a ns1:Dosage ;
            ns2:form "Injection, powder, for solution" ],
        [ a ns1:Dosage ;
            ns2:form "Solution" ;
            ns2:route "Intravenous" ;
            ns2:strength "50.0 mg" ],
        [ a ns1:Dosage ;
            ns2:form "Injection, powder, lyophilized, for solution; kit" ;
            ns2:route "Intravenous" ;
            ns2:strength "100 mg/100mL" ],
        [ a ns1:Dosage ;
            ns2:form "Solution" ;
            ns2:route "Intravenous" ;
            ns2:strength "10 mg" ],
        [ a ns1:Dosage ;
            ns2:form "Powder, for solution" ;
            ns2:route "Intravenous" ;
            ns2:strength "50 mg/50mL" ],
        [ a ns1:Dosage ;
            ns2:form "Injection, powder, for solution" ;
            ns2:route "Intravenous" ;
            ns2:strength "50 mg" ],
        [ a ns1:Dosage ;
            ns2:form "Injection, powder, for solution" ;
            ns2:route "Intravenous" ;
            ns2:strength "50 MG/50ML" ],
        [ a ns1:Dosage ;
            ns2:form "Injection, powder, lyophilized, for solution" ;
            ns2:route "Intravenous" ] .

ns2:AminoAcids a ns1:Substance .

ns2:AndexanetAlfa a ns1:Medication ;
    ns1:indication ns2:Apixaban,
        ns2:Rivaroxaban .

ns2:Anticoagulants a ns1:Medication ;
    ns1:definition "Anticoagulants may help reduce risk of subsequent strokes" ;
    ns1:name "Anticoagulants" ;
    ns1:relatedTo ns2:Emboli,
        ns2:Thrombi .

ns2:AntiphospholipidSyndrome a ns1:Condition ;
    ns1:name "Antiphospholipid Syndrome",
        "Antiphospholipid syndrome" ;
    ns1:relatedTo ns2:HypercoagulabilityDisorders .

ns2:AntiplateletTherapy a ns1:Medication,
        ns1:Procedure ;
    ns1:name "Antiplatelet Therapy",
        "Antiplatelet therapy" ;
    ns1:relatedTo ns2:IschemicStroke ;
    ns1:subject ns2:IschemicStroke .

ns2:AntipyreticMedication a ns1:Medication .

ns2:AortaDissection a ns1:Condition ;
    ns1:name "Dissection of the aorta" .

ns2:AorticArch a ns1:BodyStructure ;
    ns1:BodyStructure.location "Aortic arch" .

ns2:AorticDissection a ns1:Condition .

ns2:ArterialStenosis a ns1:Condition ;
    ns1:relatedTo ns2:IschemicStroke ;
    ns1:value "Arterial Stenosis" .

ns2:AskFamilyMembersAboutSignsOfDepression a ns1:Procedure .

ns2:AskPatientsAboutSadness a ns1:Procedure .

ns2:AtaxicHemiparesis a ns1:Symptom ;
    ns1:Symptom.description "Ataxic hemiparesis" .

ns2:AtherothromboticOcclusion a ns1:Condition ;
    ns1:definition "Occlusion of large arteries" ;
    ns1:name "Atherothrombotic occlusion" .

ns2:AtherothromboticStroke a ns1:Condition ;
    ns1:Condition.display "Atherothrombotic Stroke" ;
    ns1:Condition.symptom ns2:NeurologicDeficits ;
    ns1:Condition.time "night" .

ns2:AtrialArrhythmiasDetection a ns1:Observation ;
    ns1:name "Atrial arrhythmias detection" ;
    ns1:reasonReference ns2:CryptogenicStroke .

ns2:BacterialEndocarditis a ns1:Condition ;
    ns1:Condition.name "Bacterial endocarditis" .

ns2:BasedOnPatientHealthStatus a ns1:Timing .

ns2:BasicNeeds a ns1:Observation ;
    ns1:name "Basic Needs" .

ns2:BasilarArtery a ns1:BodySite ;
    ns1:name "Basilar artery" .

ns2:BedsideGlucoseTesting a ns1:Procedure ;
    ns1:name "Bedside Glucose Testing" .

ns2:BetterFunctionalOutcomes a ns1:Observation .

ns2:BinswangerDisease a ns1:Condition ;
    ns1:name "Binswanger Disease",
        "Binswanger disease" ;
    ns1:relatedTo ns2:RareDisorders .

ns2:Bleeding a ns1:Observation ;
    ns1:name "Bleeding" ;
    ns1:partOf ns2:Tumor .

ns2:BleedingRisk a ns1:RiskAssessment ;
    ns1:RiskAssessment.condition ns2:AcutePericarditis,
        ns2:AdvancedAge,
        ns2:CerebrovascularDisease,
        ns2:CurrentUseOfAnticoagulants,
        ns2:HemorrhagicDiabeticRetinopathy,
        ns2:HemostaticDefects,
        ns2:Hypertension,
        ns2:Pregnancy,
        ns2:RecentGastrointestinalBleeding,
        ns2:RecentIntracranialHemorrhage,
        ns2:RecentMajorSurgery,
        ns2:RecentTrauma,
        ns2:SepticThrombophlebitis,
        ns2:SignificantHepaticDysfunction,
        ns2:SubacuteBacterialEndocarditis .

ns2:BloodRelatedCauses a ns1:Condition ;
    ns1:name "Blood-related causes" .

ns2:BrainAssessment a ns1:Procedure ;
    ns1:name "Brain assessment" .

ns2:BrainTissue a ns1:AnatomicalStructure ;
    ns1:name "Brain tissue" ;
    ns1:partOf ns2:CerebralHemispheres .

ns2:CTAngiography a ns1:Procedure ;
    ns1:avoids ns2:MotionArtifacts ;
    ns1:name "CT angiography (CTA)" ;
    ns1:partOf ns2:Testing ;
    ns1:preferredOver ns2:MagneticResonanceAngiography ;
    ns1:relatedTo ns2:AnteriorCirculation,
        ns2:PosteriorCirculation .

ns2:CarbonMonoxideToxicity a ns1:Condition ;
    ns1:name "Carbon Monoxide Toxicity",
        "Carbon monoxide toxicity" ;
    ns1:relatedTo ns2:SystemicPerfusionImpairment .

ns2:CardiacThrombi a ns1:Condition ;
    ns1:Condition.associatedWith ns2:AtrialFibrillation,
        ns2:AtrialMyxoma,
        ns2:MechanicalCirculatoryAssistDevices,
        ns2:PostMyocardialInfarction,
        ns2:ProstheticHeartValves,
        ns2:RheumaticHeartDisease,
        ns2:VegetationsOnHeartValves ;
    ns1:Condition.name "Cardiac thrombi" .

ns2:CarotidArteryStenosis a ns1:Condition ;
    ns1:name "Carotid artery stenosis" .

ns2:CarotidBifurcation a ns1:BodySite ;
    ns1:name "Carotid bifurcation" .

ns2:CarotidEndarterectomy a ns1:Procedure ;
    ns1:context "sometimes" ;
    ns1:definition "Carotid endarterectomy may help reduce risk of subsequent strokes" ;
    ns1:name "Carotid endarterectomy" ;
    ns1:subject ns2:IschemicStroke .

ns2:Catheterization a ns1:Procedure ;
    ns1:Procedure.name "Catheterization" .

ns2:CerebralArterialTree a ns1:BodyStructure ;
    ns1:BodyStructure.location "Cerebral arterial tree" .

ns2:CerebralEdema a ns1:Condition ;
    ns1:Condition.name "Cerebral Edema" ;
    ns1:Condition.symptom ns2:ImpairedConsciousness .

ns2:CerebralEmbolism a ns1:Condition ;
    ns1:definition "Embolic infarction" ;
    ns1:name "Cerebral embolism" .

ns2:CerebrovascularDisease a ns1:Condition .

ns2:CertainDrugsUse a ns1:Condition ;
    ns1:name "Use of certain drugs" .

ns2:CircleOfWillis a ns1:AnatomicalStructure ;
    ns1:name "Circle of Willis" ;
    ns1:partOf ns2:EfficientCollateralSystem .

ns2:ClearSensorium a ns1:Observation ;
    ns1:name "Clear Sensorium" .

ns2:ClinicalDiagnosis a ns1:Procedure ;
    ns1:definition "Diagnosis is clinical" ;
    ns1:name "Clinical diagnosis" .

ns2:ClinicalEvaluation a ns1:Procedure ;
    ns1:name "Clinical Evaluation" .

ns2:Clinicians a ns1:Practitioner .

ns2:Clots a ns1:Condition ;
    ns1:Condition.associatedWith ns2:OpenHeartSurgery ;
    ns1:Condition.name "Clots" .

ns2:ComaOrStupor a ns1:Symptom ;
    ns1:name "Coma or Stupor" .

ns2:CombinedHemiparesisAndHemianesthesia a ns1:Symptom ;
    ns1:Symptom.description "Combined hemiparesis and hemianesthesia" .

ns2:ControlOfRiskFactors a ns1:Observation .

ns2:ControllingHyperglycemiaAndFever a ns1:Procedure ;
    ns1:Procedure.outcome ns2:BetterFunctionalOutcomes,
        ns2:LimitBrainDamage .

ns2:CoronaryArteryBypassGraft a ns1:Procedure .

ns2:CorrectionOfHyperthermia a ns1:Procedure ;
    ns1:indication ns2:Hyperthermia ;
    ns1:method ns2:AntipyreticMedication,
        ns2:IdentifyAndTreatCauseOfHypothermia .

ns2:CurrentUseOfAnticoagulants a ns1:Condition ;
    ns1:Condition.example ns2:Warfarin .

ns2:DecompressionSickness a ns1:Condition ;
    ns1:Condition.name "Decompression sickness" .

ns2:DeepPerforatingArteries a ns1:BodySite ;
    ns1:name "Deep perforating arteries" .

ns2:DeepVenousThrombosisProphylaxis a ns1:Condition .

ns2:DenseMiddleCerebralArterySign a ns1:Observation ;
    ns1:name "Dense middle cerebral artery sign" ;
    ns1:partOf ns2:AnteriorCirculationIschemicStroke .

ns2:DiastolicBP a ns1:Observation ;
    ns1:Observation.value "110 mm Hg" .

ns2:DiffusionWeightedMRI a ns1:ImagingStudy ;
    ns1:characteristic ns2:HighlySensitiveForEarlyIschemia ;
    ns1:name "Diffusion-weighted MRI" ;
    ns1:partOf ns2:Neuroimaging .

ns2:DysarthriaClumsyHandSyndrome a ns1:Symptom ;
    ns1:Symptom.description "Dysarthria–clumsy hand syndrome" .

ns2:ESUS a ns1:Condition ;
    ns1:definition "A subcategory of cryptogenic stroke, is diagnosed when no source has been identified after sufficient diagnostic evaluation has excluded lacunar stroke, major cardioembolic sources, and ipsilateral steno-occlusive vessel disease (> 50% occlusion)." ;
    ns1:excludes ns2:IpsilateralStenoOcclusiveVesselDisease,
        ns2:LacunarStroke,
        ns2:MajorCardioembolicSources ;
    ns1:name "Embolic stroke of undetermined source (ESUS)" .

ns2:EarlyImprovement a ns1:Observation ;
    ns1:name "Early Improvement" ;
    ns1:suggests ns2:FavorablePrognosis .

ns2:EffacementOfSulci a ns1:Observation ;
    ns1:name "Effacement of sulci" ;
    ns1:partOf ns2:AnteriorCirculationIschemicStroke .

ns2:EmboliProtectionDevice a ns1:Device ;
    ns1:type "filter" .

ns2:EmbolicStrokeOfUndeterminedCause a ns1:Condition .

ns2:EndOrganDamage a ns1:Condition ;
    ns1:includes ns2:AcuteMyocardialInfarction,
        ns2:AcuteRenalFailure,
        ns2:AorticDissection,
        ns2:HypertensiveEncephalopathy,
        ns2:PulmonaryEdema,
        ns2:RetinalHemorrhages .

ns2:Endocarditis a ns1:Condition ;
    ns1:code [ a ns1:CodeableConcept ;
            ns1:coding [ a ns1:Coding ;
                    ns1:code "56819008" ;
                    ns1:display "Endocarditis" ;
                    ns1:system "http://snomed.info/sct" ] ] .

ns2:EnteralNutrition a ns1:Procedure ;
    ns1:Procedure.timing ns2:Within7DaysOfAdmission .

ns2:ExcessAlcoholConsumption a ns1:Condition ;
    ns1:name "Excess alcohol consumption" .

ns2:ExcitatoryNeurotoxins a ns1:Substance ;
    ns1:example ns2:Glutamate .

ns2:ExogenousEstrogenUse a ns1:Condition ;
    ns1:name "Use of exogenous estrogen" .

ns2:ExtracranialArteries a ns1:BodySite ;
    ns1:name "Extracranial arteries" .

ns2:FamilyHistoryOfStroke a ns1:Condition ;
    ns1:name "Family history of stroke" .

ns2:Fat a ns1:Substance ;
    ns1:Substance.name "Fat" ;
    ns1:Substance.origin ns2:FracturedLongBones .

ns2:FatEmboli a ns1:Condition ;
    ns1:code [ a ns1:CodeableConcept ;
            ns1:coding [ a ns1:Coding ;
                    ns1:code "212372004" ;
                    ns1:display "Fat Emboli" ;
                    ns1:system "http://snomed.info/sct" ] ] .

ns2:Fever a ns1:Symptom ;
    ns1:Symptom.description "Occasionally, fever develops" .

ns2:FibrinBinding a ns1:Property .

ns2:FibromuscularDysplasia a ns1:Condition ;
    ns1:code [ a ns1:CodeableConcept ;
            ns1:coding [ a ns1:Coding ;
                    ns1:code "31653004" ;
                    ns1:display "Fibromuscular dysplasia" ;
                    ns1:system "http://snomed.info/sct" ] ] ;
    ns1:relatedTo ns2:RareDisorders .

ns2:FirstStroke a ns1:Observation ;
    ns1:name "First Stroke" .

ns2:FocalNeurologicSigns a ns1:Observation ;
    ns1:name "Focal Neurologic Signs" ;
    ns1:relatedTo ns2:CNSInfections,
        ns2:FunctionalNeurologicDisorders,
        ns2:Hypoglycemia,
        ns2:Migraine,
        ns2:Seizures .

ns2:FracturedLongBones a ns1:Condition ;
    ns1:Condition.value "Fractured long bones" .

ns2:FreeRadicals a ns1:Substance .

ns2:FunctionalImpairment a ns1:Observation ;
    ns1:name "Functional Impairment" .

ns2:GenitourinaryBleeding a ns1:Condition .

ns2:Glutamate a ns1:Substance .

ns2:GuidelinesForEarlyManagement a ns1:Guideline ;
    ns1:providedBy ns2:AmericanHeartAssociation,
        ns2:AmericanStrokeAssociation .

ns2:HeartDisorders a ns1:Condition ;
    ns1:name "Heart disorders" .

ns2:Hemoglobinopathies a ns1:Condition ;
    ns1:name "Hemoglobinopathies" ;
    ns1:relatedTo ns2:HyperviscosityDisorders .

ns2:HemorrhagicDiabeticRetinopathy a ns1:Condition ;
    ns1:Condition.example ns2:HemorrhagicOphthalmicConditions .

ns2:HemorrhagicOphthalmicConditions a ns1:Condition .

ns2:HemostaticDefects a ns1:Condition ;
    ns1:Condition.example ns2:RenalDisease,
        ns2:SevereHepaticDisease .

ns2:HighBloodPressure a ns1:Observation ;
    ns1:management ns2:LoweringBPBy15Percent ;
    ns1:monitoringInterval "15 minutes" ;
    ns1:threshold "≥ 220 mm Hg systolic or ≥ 120 mm Hg diastolic" .

ns2:HighRiskDiet a ns1:Condition ;
    ns1:name "High-risk diet" .

ns2:HighSurgicalRiskPatients a ns1:Patient .

ns2:HighlySensitiveForEarlyIschemia a ns1:Observation ;
    ns1:name "Highly sensitive for early ischemia" ;
    ns1:partOf ns2:DiffusionWeightedMRI .

ns2:Hospitalization a ns1:Procedure .

ns2:Hypercoagulability a ns1:Condition ;
    ns1:name "Hypercoagulability" .

ns2:Hyperglycemia a ns1:Observation .

ns2:Hyperhomocysteinemia a ns1:Condition ;
    ns1:code [ a ns1:CodeableConcept ;
            ns1:coding [ a ns1:Coding ;
                    ns1:code "419503008" ;
                    ns1:display "Hyperhomocysteinemia" ;
                    ns1:system "http://snomed.info/sct" ] ] ;
    ns1:relatedTo ns2:HypercoagulabilityDisorders .

ns2:HypertensiveEncephalopathy a ns1:Condition .

ns2:Hyperthermia a ns1:Condition,
        ns1:Observation ;
    ns1:code [ a ns1:CodeableConcept ;
            ns1:coding [ a ns1:Coding ;
                    ns1:code "1197782006" ;
                    ns1:display "Hyperthermia" ;
                    ns1:system "http://snomed.info/sct" ] ] ;
    ns1:threshold "> 38° C" .

ns2:Hypotension a ns1:Condition ;
    ns1:code [ a ns1:CodeableConcept ;
            ns1:coding [ a ns1:Coding ;
                    ns1:code "45007003" ;
                    ns1:display "Hypotension" ;
                    ns1:system "http://snomed.info/sct" ] ] ;
    ns1:relatedTo ns2:IschemicStroke,
        ns2:SystemicPerfusionImpairment .

ns2:Hypoxia a ns1:Condition ;
    ns1:code [ a ns1:CodeableConcept ;
            ns1:coding [ a ns1:Coding ;
                    ns1:code "389086002" ;
                    ns1:display "Hypoxia" ;
                    ns1:system "http://snomed.info/sct" ] ] ;
    ns1:relatedTo ns2:SystemicPerfusionImpairment .

ns2:IVThrombolysis a ns1:Procedure ;
    ns1:name "IV thrombolysis" .

ns2:IVtPA a ns1:Medication ;
    ns1:name "IV tPA" .

ns2:Idarucizumab a ns1:Medication ;
    ns1:indication ns2:Dabigatran .

ns2:IdentifyAndTreatCauseOfHypothermia a ns1:Procedure .

ns2:IdentifyRiskOfAspiration a ns1:Observation .

ns2:InadequateBloodFlow a ns1:Condition ;
    ns1:bodySite ns2:BrainArtery ;
    ns1:name "Inadequate blood flow" .

ns2:IncreasedIntracranialPressure a ns1:Condition .

ns2:InfarctionWithCellNecrosis a ns1:Condition .

ns2:InsularCorticalRibbon a ns1:Observation ;
    ns1:name "Insular cortical ribbon" ;
    ns1:partOf ns2:AnteriorCirculationIschemicStroke .

ns2:InsulinResistance a ns1:Condition ;
    ns1:name "Insulin resistance" .

ns2:Interleukin1Beta a ns1:Substance .

ns2:IntermittentPneumaticCompression a ns1:Procedure ;
    ns1:Procedure.reason ns2:DeepVenousThrombosisProphylaxis ;
    ns1:Procedure.subject ns2:ImmobileStrokePatientsWithoutContraindications .

ns2:InternalCarotidArteryOcclusion a ns1:Condition ;
    ns1:name "Internal carotid artery occlusion" .

ns2:InternalCarotidArterySegment a ns1:BodySite ;
    ns1:name "Segment of the internal carotid artery between the cavernous sinus and supraclinoid process" .

ns2:InterventionistsExperience a ns1:Observation .

ns2:IntracellularAcidosis a ns1:Condition ;
    ns1:dueTo ns2:AccumulationOfLactate .

ns2:IntracellularCalciumAccumulation a ns1:Condition .

ns2:IntracranialArteries a ns1:BodySite ;
    ns1:name "Intracranial arteries" .

ns2:IntracranialArteriesDissection a ns1:Condition ;
    ns1:name "Dissection of intracranial arteries" .

ns2:IntracranialInfection a ns1:Condition ;
    ns1:relatedTo ns2:VenousSinusThrombosis ;
    ns1:value "Intracranial Infection" .

ns2:InvasiveCardiovascularProcedures a ns1:Procedure ;
    ns1:Procedure.display "Invasive cardiovascular procedures" ;
    ns1:Procedure.example ns2:Catheterization .

ns2:IpsilateralCarotidObstruction a ns1:Condition ;
    ns1:severity "70 to 99% of the arterial lumen" .

ns2:IpsilateralStenoOcclusiveVesselDisease a ns1:Condition ;
    ns1:definition "> 50% occlusion" ;
    ns1:value "Ipsilateral steno-occlusive vessel disease" .

ns2:IronMediatedProcess a ns1:Process .

ns2:LackOfPhysicalActivity a ns1:Condition ;
    ns1:name "Lack of physical activity" .

ns2:LacunarStroke a ns1:Condition ;
    ns1:name "Lacunar Stroke" .

ns2:LargeArteriesAtBaseOfBrain a ns1:BodySite ;
    ns1:description "Large arteries at the base of the brain" .

ns2:LargeInfarct a ns1:Condition ;
    ns1:characteristic ns2:Hypodensity ;
    ns1:diagnosedBy ns2:CT ;
    ns1:name "Large infarct" .

ns2:LeftVentricularAssistDevice a ns1:Device ;
    ns1:Device.name "Left ventricular assist device" .

ns2:LimitBrainDamage a ns1:Observation .

ns2:LipidPeroxidativeDamage a ns1:Condition ;
    ns1:process ns2:FreeRadicals,
        ns2:IronMediatedProcess .

ns2:Lipohyalinosis a ns1:Condition ;
    ns1:definition "Degeneration of the media of small arteries and replacement by lipids and collagen." ;
    ns1:name "Lipohyalinosis" .

ns2:LiverFailure a ns1:Condition ;
    ns1:criteria "elevated INR" .

ns2:LongTermManagement a ns1:Procedure ;
    ns1:Procedure.supportingInformation ns2:PreventionOfRecurrentStroke,
        ns2:TreatmentOfDepression .

ns2:LossOfATPStores a ns1:Condition .

ns2:LossOfGrayWhiteJunction a ns1:Observation ;
    ns1:description "Loss of the gray-white junction" ;
    ns1:partOf ns2:AnteriorCirculationIschemicStroke .

ns2:LossOfIonicHomeostasis a ns1:Condition ;
    ns1:includes ns2:IntracellularCalciumAccumulation .

ns2:LowMolecularWeightHeparin a ns1:Medication ;
    ns1:Medication.subject ns2:ImmobileStrokePatientsWithoutContraindications .

ns2:LowRateOfPeriproceduralAdverseEvents a ns1:Observation .

ns2:LoweringBPBy15Percent a ns1:Procedure ;
    ns1:timeframe "24 hours after stroke onset" .

ns2:MajorCardioembolicSources a ns1:Condition ;
    ns1:name "Major cardioembolic sources" .

ns2:MajorCerebralArtery a ns1:BodySite ;
    ns1:name "Major cerebral artery" .

ns2:MaranticEndocarditis a ns1:Condition ;
    ns1:Condition.name "Marantic endocarditis" .

ns2:MaximizeFunction a ns1:Observation .

ns2:MechanicalThrombectomy a ns1:Procedure ;
    ns1:description "angiographically directed intra-arterial removal of a thrombus or embolus by a stent retriever device" ;
    ns1:indication ns2:InternalCarotidArteryOcclusion,
        ns2:LargeMismatchBetweenInfarctVolumeAndClinicalDeficit,
        ns2:LargerPenumbra,
        ns2:MiddleCerebralArteryOcclusion,
        ns2:SmallInfarct,
        ns2:TissueAtRiskOfInfarction,
        "recent large-vessel occlusion in the anterior circulation" ;
    ns1:name "Mechanical Thrombectomy" ;
    ns1:outcome ns2:ReestablishPerfusion ;
    ns1:relatedTo ns2:Emboli,
        ns2:IschemicStroke,
        ns2:Thrombi ;
    ns1:setting "large stroke centers" ;
    ns1:status "standard of care" ;
    ns1:useContext ns2:IVThrombolysis,
        ns2:NIHSSScoreGreaterThan6,
        ns2:NIHSSScoreLessThan6,
        ns2:PosteriorCirculationStrokes,
        ns2:SymptomOnset16Hours,
        ns2:SymptomOnset24Hours,
        ns2:SymptomOnset6Hours .

ns2:MediumSizedInfarct a ns1:Condition ;
    ns1:characteristic ns2:Hypodensity ;
    ns1:diagnosedBy ns2:CT ;
    ns1:name "Medium-sized infarct" .

ns2:MiddleCerebralArtery a ns1:BodySite ;
    ns1:name "Middle cerebral artery" .

ns2:MiddleCerebralArteryOcclusion a ns1:Condition ;
    ns1:name "Middle cerebral artery occlusion" .

ns2:Migraine a ns1:Condition ;
    ns1:name "Migraine" ;
    ns1:relatedTo ns2:HemiplegicMigraine,
        ns2:Vasospasm .

ns2:Mild a ns1:Observation ;
    ns1:name "Mild" .

ns2:MitralStenosis a ns1:Condition ;
    ns1:Condition.name "Mitral stenosis" .

ns2:Moderate a ns1:Observation ;
    ns1:name "Moderate" .

ns2:ModifiableRiskFactors a ns1:Observation ;
    ns1:Observation.component ns2:AlcoholUseDisorder,
        ns2:Diabetes,
        ns2:Dyslipidemia,
        ns2:Hypertension,
        ns2:Obesity,
        ns2:Smoking .

ns2:MotionArtifacts a ns1:Observation ;
    ns1:name "Motion artifacts" .

ns2:MoyamoyaDisease a ns1:Condition ;
    ns1:name "Moyamoya Disease",
        "Moyamoya disease" ;
    ns1:relatedTo ns2:RareDisorders .

ns2:MultiInfarctDementia a ns1:Condition ;
    ns1:Condition.cause ns2:LacunarInfarcts ;
    ns1:Condition.name "Multi-Infarct Dementia" .

ns2:MyocardialInfarction a ns1:Condition ;
    ns1:occurrence "periprocedural period" .

ns2:NIHSSScoreGreaterThan6 a ns1:Observation ;
    ns1:name "NIHSS score > 6" .

ns2:NIHSSScoreLessThan6 a ns1:Observation ;
    ns1:name "NIHSS score < 6" .

ns2:NIHStrokeScale a ns1:Observation ;
    ns1:name "NIH Stroke Scale" .

ns2:NeckArteries a ns1:BodyStructure ;
    ns1:BodyStructure.location "Neck arteries" .

ns2:NeurologicRecovery a ns1:Observation ;
    ns1:completeRecoveryRate "10%" ;
    ns1:name "Neurologic Recovery" ;
    ns1:permanentDeficitsAfter "12 months" .

ns2:Neurons a ns1:AnatomicalStructure ;
    ns1:name "Neurons" .

ns2:NonCerebrovascularDisorders a ns1:Condition ;
    ns1:name "Non-Cerebrovascular Disorders" ;
    ns1:relatedTo ns2:FocalNeurologicSigns .

ns2:NonatherothromboticObstruction a ns1:Condition ;
    ns1:causedBy ns2:Lipohyalinosis ;
    ns1:definition "Obstruction of small, perforating arteries that supply deep cortical structures." ;
    ns1:name "Nonatherothrombotic obstruction" .

ns2:NonthromboticOcclusion a ns1:Condition ;
    ns1:definition "Occlusion of small, deep cerebral arteries (lacunar infarction)" ;
    ns1:name "Nonthrombotic occlusion" .

ns2:Obesity a ns1:Condition .

ns2:ObstetricalDelivery a ns1:Procedure .

ns2:ObstructiveSleepApnea a ns1:Condition ;
    ns1:name "Obstructive sleep apnea" .

ns2:OccludedArteriovenousCannulaAtInfectedSite a ns1:Condition .

ns2:OptimalTreatmentWithMedicationsIneffective a ns1:Condition .

ns2:OrganBiopsy a ns1:Procedure .

ns2:OtherCardiovascularEvents a ns1:Condition .

ns2:OxygenSaturationBelow94 a ns1:Observation .

ns2:PatentForamenOvaleWithShunt a ns1:Condition ;
    ns1:Condition.display "Patent foramen ovale with shunt" ;
    ns1:Condition.resultIn ns2:ParadoxicalEmboli .

ns2:Patient a ns1:Patient .

ns2:PatientCharacteristics a ns1:Observation ;
    ns1:component ns2:AdherenceToMedicationRegimen,
        ns2:ControlOfRiskFactors .

ns2:PatientsOver70Years a ns1:Patient .

ns2:PeripartumState a ns1:Condition ;
    ns1:name "Peripartum State" ;
    ns1:relatedTo ns2:VenousSinusThrombosis .

ns2:PhysicalTherapy a ns1:Procedure ;
    ns1:Procedure.outcome ns2:MaximizeFunction,
        ns2:PreventJointContractures,
        ns2:PreventSarcopenia .

ns2:PlasmaCellDisorders a ns1:Condition ;
    ns1:name "Plasma Cell Disorders",
        "Plasma cell disorders" ;
    ns1:relatedTo ns2:HyperviscosityDisorders .

ns2:PlasminogenActivatorInhibitorResistance a ns1:Property .

ns2:PlasminogenConversion a ns1:Property .

ns2:Polycythemia a ns1:Condition ;
    ns1:code [ a ns1:CodeableConcept ;
            ns1:coding [ a ns1:Coding ;
                    ns1:code "127062003" ;
                    ns1:display "Polycythemia" ;
                    ns1:system "http://snomed.info/sct" ] ] ;
    ns1:relatedTo ns2:HyperviscosityDisorders .

ns2:PosteriorCirculationStrokes a ns1:Condition ;
    ns1:name "Posterior circulation strokes" .

ns2:PostoperativeState a ns1:Condition ;
    ns1:name "Postoperative State" ;
    ns1:relatedTo ns2:VenousSinusThrombosis .

ns2:Pregnancy a ns1:Condition .

ns2:PreventJointContractures a ns1:Observation .

ns2:PreventPressureUlcers a ns1:Procedure ;
    ns1:Procedure.timing ns2:StartedEarly .

ns2:PreventSarcopenia a ns1:Observation .

ns2:PreventionOfRecurrentStroke a ns1:Procedure ;
    ns1:Procedure.reason ns2:SecondaryPrevention ;
    ns1:Procedure.supportingInformation ns2:ModifiableRiskFactors,
        ns2:ReducingSystolicBP .

ns2:PreviousPunctureOfNoncompressibleVessels a ns1:Procedure .

ns2:PrimaryPrevention a ns1:Condition .

ns2:PriorStroke a ns1:Condition ;
    ns1:name "Prior stroke" .

ns2:Prognosis a ns1:Observation ;
    ns1:name "Prognosis" ;
    ns1:relatedTo ns2:Aphasia,
        ns2:BrainStemSigns,
        ns2:EarlyImprovement,
        ns2:ImpairedConsciousness,
        ns2:OlderAge,
        ns2:YoungerAge .

ns2:ProgrammedCellDeath a ns1:Condition ;
    ns1:alias "Apoptosis" .

ns2:ProximalArterialStenosis a ns1:Condition ;
    ns1:definition "Stenosis with hypotension that decreases cerebral blood flow in arterial watershed zones (hemodynamic stroke)" ;
    ns1:name "Proximal arterial stenosis" .

ns2:PsychosocialStress a ns1:Condition ;
    ns1:value "Psychosocial stress" .

ns2:PulmonaryEdema a ns1:Condition .

ns2:PureMotorHemiparesis a ns1:Symptom ;
    ns1:Symptom.description "Pure motor hemiparesis" .

ns2:PureSensoryHemianesthesia a ns1:Symptom ;
    ns1:Symptom.description "Pure sensory hemianesthesia" .

ns2:RaceEthnicity a ns1:Condition ;
    ns1:name "Race/ethnicity" .

ns2:RapidlyGrowing a ns1:Observation ;
    ns1:name "Rapidly growing" ;
    ns1:partOf ns2:Tumor .

ns2:RecentGastrointestinalBleeding a ns1:Condition ;
    ns1:Condition.example ns2:GenitourinaryBleeding .

ns2:RecentIntracranialHemorrhage a ns1:Condition .

ns2:RecentMajorSurgery a ns1:Condition ;
    ns1:Condition.example ns2:CoronaryArteryBypassGraft,
        ns2:ObstetricalDelivery,
        ns2:OrganBiopsy,
        ns2:PreviousPunctureOfNoncompressibleVessels .

ns2:RecentTrauma a ns1:Condition .

ns2:RecurrentStroke a ns1:Condition ;
    ns1:occurrence "periprocedural period" .

ns2:RecurrentSymptomsOfVertebrobasilarIschemia a ns1:Condition .

ns2:ReducingSystolicBP a ns1:Procedure ;
    ns1:Procedure.target ns2:TargetBP120mmHg,
        ns2:TypicalLevel140mmHg ;
    ns1:Procedure.timing ns2:BasedOnPatientHealthStatus,
        ns2:OtherCardiovascularEvents,
        ns2:RiskOfRecurrentStroke .

ns2:RenalDisease a ns1:Condition .

ns2:RetinalHemorrhages a ns1:Condition .

ns2:RheumaticDisorders a ns1:Condition ;
    ns1:name "Rheumatic Disorders" ;
    ns1:relatedTo ns2:IschemicStroke .

ns2:RiskOfRecurrentStroke a ns1:Condition .

ns2:ScreeningForDysphagia a ns1:Procedure ;
    ns1:Procedure.outcome ns2:IdentifyRiskOfAspiration ;
    ns1:Procedure.performer ns2:SpeechLanguagePathologist,
        ns2:TrainedHealthCarePractitioner .

ns2:SecondaryPrevention a ns1:Condition .

ns2:SecondaryPreventionOfCardioembolicStrokes a ns1:Condition .

ns2:Seizures a ns1:Condition ;
    ns1:name "Seizures" ;
    ns1:relatedTo ns2:PostictalParalysis .

ns2:SepticThrombophlebitis a ns1:Condition ;
    ns1:Condition.example ns2:OccludedArteriovenousCannulaAtInfectedSite .

ns2:SerumCreatinineOver1.5mgdL a ns1:Observation ;
    ns1:criteria "serum creatinine ≥ 1.5mg/dL" .

ns2:Severe a ns1:Observation ;
    ns1:name "Severe" .

ns2:SevereAnemia a ns1:Condition ;
    ns1:name "Severe Anemia",
        "Severe anemia" ;
    ns1:relatedTo ns2:SystemicPerfusionImpairment .

ns2:SevereHepaticDisease a ns1:Condition .

ns2:SevereIschemia a ns1:Condition ;
    ns1:name "Severe ischemia" ;
    ns1:relatedTo ns2:BrainIschemia .

ns2:Sex a ns1:Condition ;
    ns1:name "Sex" .

ns2:SickleCellDisease a ns1:Condition ;
    ns1:name "Sickle Cell Disease",
        "Sickle cell disease" ;
    ns1:relatedTo ns2:Stroke .

ns2:SignificantHepaticDysfunction a ns1:Condition .

ns2:SingleBolusAdministration a ns1:Property .

ns2:SmallCorticalBranches a ns1:BodySite ;
    ns1:name "Small cortical branches" .

ns2:SpecificArterialTerritory a ns1:BodyStructure ;
    ns1:name "Specific Arterial Territory" .

ns2:SpeechLanguagePathologist a ns1:Practitioner .

ns2:Spontaneously a ns1:Event ;
    ns1:Event.name "Spontaneously" .

ns2:StartedEarly a ns1:Timing .

ns2:Statins a ns1:Medication ;
    ns1:description "Used to prevent recurrent strokes; lipid levels must be decreased by substantial amounts." .

ns2:Stenting a ns1:Procedure ;
    ns1:context "sometimes" ;
    ns1:definition "Stenting may help reduce risk of subsequent strokes" ;
    ns1:name "Stenting" ;
    ns1:relatedTo ns2:IschemicStroke ;
    ns1:subject ns2:IschemicStroke .

ns2:StrokeOutcome a ns1:Observation ;
    ns1:name "Stroke Outcome" ;
    ns1:relatedTo ns2:Hemiplegia,
        ns2:MortalityRate,
        ns2:NeurologicRecovery,
        ns2:SubsequentStrokes .

ns2:StrokeSeverity a ns1:Observation ;
    ns1:correlatesWith ns2:FunctionalImpairment,
        ns2:Prognosis ;
    ns1:method ns2:NIHStrokeScale .

ns2:SubacuteBacterialEndocarditis a ns1:Condition .

ns2:SubarachnoidHemorrhage a ns1:Condition ;
    ns1:name "Subarachnoid Hemorrhage",
        "Subarachnoid hemorrhage" ;
    ns1:relatedTo ns2:Vasospasm .

ns2:SubclavianArteryThrombosis a ns1:Condition ;
    ns1:name "Subclavian artery thrombosis" .

ns2:SubsequentStrokes a ns1:Observation ;
    ns1:highRiskAfter ns2:FirstStroke ;
    ns1:name "Subsequent Strokes" ;
    ns1:recurrencePeriod "5 years" ;
    ns1:recurrenceRate "25%" .

ns2:SuddenlySymptomatic a ns1:Observation ;
    ns1:name "Suddenly symptomatic" ;
    ns1:partOf ns2:Tumor .

ns2:SupplementalOxygen a ns1:Procedure ;
    ns1:indication ns2:OxygenSaturationBelow94 .

ns2:SupportiveCare a ns1:Procedure ;
    ns1:Procedure.supportingInformation ns2:ControllingHyperglycemiaAndFever,
        ns2:EnteralNutrition,
        ns2:IntermittentPneumaticCompression,
        ns2:LowMolecularWeightHeparin,
        ns2:PhysicalTherapy,
        ns2:PreventPressureUlcers,
        ns2:ScreeningForDysphagia .

ns2:SupportiveMeasures a ns1:Procedure ;
    ns1:includes ns2:AirwaySupport,
        ns2:CorrectionOfHyperthermia,
        ns2:SupplementalOxygen,
        ns2:TreatmentOfHyperglycemia,
        ns2:TreatmentOfHypoglycemia,
        ns2:VentilatoryAssistance .

ns2:SympathomimeticDrugsUse a ns1:Condition ;
    ns1:name "Use of sympathomimetic drugs" .

ns2:SymptomOnset6Hours a ns1:Observation ;
    ns1:name "Symptom onset within 6 hours" .

ns2:Syphilis a ns1:Condition ;
    ns1:name "Syphilis" ;
    ns1:relatedTo ns2:VascularInflammation .

ns2:SystolicBP a ns1:Observation ;
    ns1:Observation.value "175 mm Hg" .

ns2:TargetBP120mmHg a ns1:Observation .

ns2:TherapeuticWindow a ns1:Property .

ns2:Thrombocytosis a ns1:Condition ;
    ns1:code [ a ns1:CodeableConcept ;
            ns1:coding [ a ns1:Coding ;
                    ns1:code "6631009" ;
                    ns1:display "Thrombocytosis" ;
                    ns1:system "http://snomed.info/sct" ] ] ;
    ns1:relatedTo ns2:HyperviscosityDisorders .

ns2:ThrombolyticTherapy a ns1:Procedure ;
    ns1:definition "Thrombolytic therapy may be useful acutely in certain patients" ;
    ns1:name "Thrombolytic Therapy",
        "Thrombolytic therapy" ;
    ns1:relatedTo ns2:IschemicStroke .

ns2:ThromboticDisorders a ns1:Condition ;
    ns1:relatedTo ns2:IschemicStroke ;
    ns1:value "Thrombotic Disorders",
        "Thrombotic disorders" .

ns2:TimingOfProcedure a ns1:Observation ;
    ns1:value "> 3 weeks after the stroke" .

ns2:TissueAtRiskOfInfarction a ns1:Condition ;
    ns1:name "Tissue at risk of infarction" .

ns2:TrainedHealthCarePractitioner a ns1:Practitioner .

ns2:TreatmentOfDepression a ns1:Procedure ;
    ns1:Procedure.outcome ns2:AidInRecovery ;
    ns1:Procedure.performer ns2:Clinicians ;
    ns1:Procedure.supportingInformation ns2:AskFamilyMembersAboutSignsOfDepression,
        ns2:AskPatientsAboutSadness .

ns2:TreatmentOfHyperglycemia a ns1:Procedure ;
    ns1:indication ns2:Hyperglycemia ;
    ns1:monitoring ns2:Hypoglycemia ;
    ns1:targetBloodGlucose "140 to 180 mg/dL" .

ns2:TreatmentOfHypoglycemia a ns1:Procedure ;
    ns1:indication ns2:Hypoglycemia .

ns2:TumorNecrosisFactorAlpha a ns1:Substance .

ns2:TypicalLevel140mmHg a ns1:Observation .

ns2:UnderlyingMalignancy a ns1:Condition ;
    ns1:name "Underlying Malignancy" ;
    ns1:relatedTo ns2:HypercoagulabilityDisorders .

ns2:UnilateralNeurologicDysfunction a ns1:Symptom ;
    ns1:Symptom.description "Unilateral neurologic dysfunction often beginning in one arm, then spreading ipsilaterally" .

ns2:UseOfTPA a ns1:Procedure .

ns2:ValvularAtrialFibrillation a ns1:Condition .

ns2:VascularCauses a ns1:Condition ;
    ns1:name "Vascular causes" .

ns2:VasculiticDisorders a ns1:Condition ;
    ns1:name "Vasculitic Disorders",
        "Vasculitic disorders" ;
    ns1:relatedTo ns2:VascularInflammation .

ns2:Vasculitis a ns1:Condition ;
    ns1:name "Vasculitis" .

ns2:VegetationsOnHeartValves a ns1:Condition ;
    ns1:Condition.associatedWith ns2:BacterialEndocarditis,
        ns2:MaranticEndocarditis ;
    ns1:Condition.name "Vegetations on heart valves" .

ns2:VenousClots a ns1:Condition ;
    ns1:Condition.name "Venous clots" ;
    ns1:Condition.pathway ns2:PatentForamenOvaleWithShunt .

ns2:VentilatoryAssistance a ns1:Procedure ;
    ns1:indication ns2:BulbarDysfunction,
        ns2:DecreasedConsciousness .

ns2:VertebralArtery a ns1:AnatomicalStructure,
        ns1:BodyStructure ;
    ns1:BodyStructure.location "Vertebral artery" ;
    ns1:name "Vertebral artery" ;
    ns1:partOf ns2:EfficientCollateralSystem .

ns2:VertebralArteryBranches a ns1:BodyStructure ;
    ns1:BodyStructure.location "Vertebral artery branches" .

ns2:VertebralArteryObstruction a ns1:Condition .

ns2:Vomiting a ns1:Symptom ;
    ns1:name "Vomiting" .

ns2:WalkingAbility a ns1:Observation ;
    ns1:name "Walking Ability" .

ns2:WeightUnder60kg a ns1:Observation ;
    ns1:criteria "weight < 60 kg" .

ns2:Within7DaysOfAdmission a ns1:Timing .

ns2:YoungerAge a ns1:Observation ;
    ns1:name "Younger Age" ;
    ns1:suggests ns2:FavorablePrognosis .

ns2:AmericanHeartAssociation a ns1:Organization .

ns2:AmericanStrokeAssociation a ns1:Organization .

ns2:Aphasia a ns1:Condition ;
    ns1:code [ a ns1:CodeableConcept ;
            ns1:coding [ a ns1:Coding ;
                    ns1:code "87486003" ;
                    ns1:display "Aphasia" ;
                    ns1:system "http://snomed.info/sct" ] ] ;
    ns1:suggests ns2:PoorPrognosis .

ns2:Apixaban a ns1:Medication ;
    ns1:dosage "5 mg twice a day" ;
    ns1:reducedDosage "2.5 mg" ;
    ns1:reducedDosageCriteria ns2:AgeOver80,
        ns2:SerumCreatinineOver1.5mgdL,
        ns2:WeightUnder60kg ;
    ns1:substance ns2:DirectFactorXaInhibitor .

ns2:AtrialFibrillation a ns1:Condition ;
    ns1:Condition.code "Atrial fibrillation" ;
    ns1:code [ a ns1:CodeableConcept ;
            ns1:coding [ a ns1:Coding ;
                    ns1:code "49436004" ;
                    ns1:display "Atrial fibrillation" ;
                    ns1:system "http://snomed.info/sct" ] ] ;
    ns1:relatedTo ns2:IschemicStroke .

ns2:AtrialMyxoma a ns1:Condition ;
    ns1:code [ a ns1:CodeableConcept ;
            ns1:coding [ a ns1:Coding ;
                    ns1:code "233854003" ;
                    ns1:display "Atrial Myxoma" ;
                    ns1:system "http://snomed.info/sct" ] ] .

ns2:BrainStemSigns a ns1:Observation ;
    ns1:name "Brain Stem Signs" ;
    ns1:suggests ns2:PoorPrognosis .

ns2:BulbarDysfunction a ns1:Condition .

ns2:CNSInfections a ns1:Condition ;
    ns1:name "CNS Infections" .

ns2:Cardioembolism a ns1:Condition ;
    ns1:hasRiskFactor ns2:AirEmboli,
        ns2:Atheromas,
        ns2:AtrialFibrillation,
        ns2:AtrialMyxoma,
        ns2:Endocarditis,
        ns2:FatEmboli,
        ns2:MechanicalCirculatoryAssistDevices,
        ns2:OpenHeartSurgery,
        ns2:ParadoxicalEmboli,
        ns2:PostMyocardialInfarction,
        ns2:ProstheticHeartValves,
        ns2:RheumaticHeartDisease,
        ns2:SubclavianArteryThrombosis ;
    ns1:value "Cardioembolism" .

ns2:CarotidObstruction a ns1:Condition ;
    ns1:severity "≥ 60%" .

ns2:CerebralHemispheres a ns1:AnatomicalStructure ;
    ns1:name "Cerebral hemispheres" .

ns2:CigaretteSmoking a ns1:Condition ;
    ns1:description "Cigarette smoking" .

ns2:Dabigatran a ns1:Medication ;
    ns1:contraindication ns2:LiverFailure,
        ns2:SevereRenalFailure ;
    ns1:dosage "150 mg twice a day" ;
    ns1:indication ns2:NonvalvularAtrialFibrillation ;
    ns1:substance ns2:DirectThrombinInhibitor .

ns2:DecreasedConsciousness a ns1:Condition .

ns2:Dyslipidemia a ns1:Condition ;
    ns1:code [ a ns1:CodeableConcept ;
            ns1:coding [ a ns1:Coding ;
                    ns1:code "370992007" ;
                    ns1:display "Dyslipidemia" ;
                    ns1:system "http://snomed.info/sct" ] ] .

ns2:Edema a ns1:Condition ;
    ns1:consequence ns2:IncreasedIntracranialPressure .

ns2:EmbolicStroke a ns1:Condition ;
    ns1:Condition.code "Embolic Stroke",
        "Embolic stroke" ;
    ns1:Condition.location ns2:VertebralArtery,
        ns2:VertebralArteryBranches ;
    ns1:Condition.symptom ns2:Headache,
        ns2:NeurologicDeficits,
        ns2:Seizure ;
    ns1:Condition.time "day" ;
    ns1:code [ a ns1:CodeableConcept ;
            ns1:coding [ a ns1:Coding ;
                    ns1:code "371041009" ;
                    ns1:display "Embolic Stroke" ;
                    ns1:system "http://snomed.info/sct" ] ] ;
    ns1:relatedTo ns2:IschemicStroke .

ns2:FavorablePrognosis a ns1:Observation ;
    ns1:value "Favorable Prognosis" .

ns2:FunctionalNeurologicDisorders a ns1:Condition ;
    ns1:note "Generally a diagnosis of exclusion" ;
    ns1:value "Functional Neurologic Disorders" .

ns2:Hemiplegia a ns1:Condition ;
    ns1:code [ a ns1:CodeableConcept ;
            ns1:coding [ a ns1:Coding ;
                    ns1:code "50582007" ;
                    ns1:display "Hemiplegia" ;
                    ns1:system "http://snomed.info/sct" ] ] ;
    ns1:relatedTo ns2:BasicNeeds,
        ns2:ClearSensorium,
        ns2:WalkingAbility ;
    ns1:severity ns2:Mild,
        ns2:Moderate,
        ns2:Severe .

ns2:HemiplegicMigraine a ns1:Condition,
        ns1:Observation ;
    ns1:value "Hemiplegic Migraine" .

ns2:HypercoagulabilityDisorder a ns1:Condition ;
    ns1:hasSubtype ns2:AntiphospholipidSyndrome,
        ns2:Hyperhomocysteinemia,
        ns2:UnderlyingMalignancy ;
    ns1:name "Hypercoagulability Disorder" ;
    ns1:relatedTo ns2:VenousSinusThrombosis .

ns2:Hypodensity a ns1:Observation ;
    ns1:name "Hypodensity" ;
    ns1:partOf ns2:LargeInfarct,
        ns2:MediumSizedInfarct .

ns2:ImmobileStrokePatientsWithoutContraindications a ns1:Patient .

ns2:Interventionists a ns1:Practitioner ;
    ns1:experience "very experienced" .

ns2:LargeMismatchBetweenInfarctVolumeAndClinicalDeficit a ns1:Observation ;
    ns1:description "Large mismatch between infarct volume and clinical deficit" .

ns2:LargeVesselAtherosclerosis a ns1:Condition ;
    ns1:bodySite ns2:ExtracranialArteries,
        ns2:IntracranialArteries ;
    ns1:hasRiskFactor ns2:Atheromas ;
    ns1:name "Large-vessel atherosclerosis" .

ns2:LargerPenumbra a ns1:Condition ;
    ns1:name "Larger penumbra" .

ns2:MagneticResonanceAngiography a ns1:Procedure ;
    ns1:name "Magnetic resonance angiography (MRA)" ;
    ns1:partOf ns2:Testing ;
    ns1:relatedTo ns2:AnteriorCirculation,
        ns2:PosteriorCirculation .

ns2:MechanicalCirculatoryAssistDevices a ns1:Condition,
        ns1:Device ;
    ns1:Device.example ns2:LeftVentricularAssistDevice ;
    ns1:name "Mechanical circulatory assist devices" .

ns2:MicrovascularThrombosis a ns1:Condition .

ns2:OlderAge a ns1:Condition,
        ns1:Observation ;
    ns1:name "Older Age",
        "Older age" ;
    ns1:suggests ns2:PoorPrognosis .

ns2:OpenHeartSurgery a ns1:Condition,
        ns1:Procedure ;
    ns1:name "Open-heart surgery" .

ns2:ParadoxicalEmboli a ns1:Condition ;
    ns1:name "Paradoxical emboli" .

ns2:PostMyocardialInfarction a ns1:Condition ;
    ns1:name "Post–myocardial infarction" .

ns2:PosteriorCirculation a ns1:BodyStructure ;
    ns1:name "Posterior circulation" .

ns2:PostictalParalysis a ns1:Condition,
        ns1:Observation ;
    ns1:name "Postictal Paralysis" .

ns2:ProstheticHeartValves a ns1:Condition,
        ns1:Device ;
    ns1:name "Prosthetic heart valves" .

ns2:RecentNondisablingSubmaximalStroke a ns1:Condition ;
    ns1:associatedWith ns2:IpsilateralCarotidObstruction .

ns2:ReestablishPerfusion a ns1:Observation ;
    ns1:name "Reestablish perfusion" .

ns2:RheumaticHeartDisease a ns1:Condition ;
    ns1:Condition.associatedWith ns2:MitralStenosis ;
    ns1:name "Rheumatic heart disease" .

ns2:Rivaroxaban a ns1:Medication ;
    ns1:contraindication ns2:SevereRenalFailure ;
    ns1:dosage "20 mg once a day" ;
    ns1:indication ns2:NonvalvularAtrialFibrillation ;
    ns1:substance ns2:DirectFactorXaInhibitor .

ns2:Seizure a ns1:Symptom ;
    ns1:Symptom.description "A seizure may occur at stroke onset, more often with embolic than thrombotic stroke. Seizures may also occur months to years later; late seizures result from scarring or hemosiderin deposition at the site of ischemia" .

ns2:SevereRenalFailure a ns1:Condition ;
    ns1:criteria "creatinine clearance < 15 mL/minute" .

ns2:Smoking a ns1:Condition ;
    ns1:definition "The act of inhaling and exhaling the smoke of tobacco or a drug." ;
    ns1:name "Smoking" .

ns2:Surgeons a ns1:Practitioner ;
    ns1:experience "very experienced" .

ns2:SympathomimeticDrugUse a ns1:Condition ;
    ns1:name "Sympathomimetic Drug Use" ;
    ns1:relatedTo ns2:Vasospasm .

ns2:SymptomOnset16Hours a ns1:Observation ;
    ns1:name "Symptom onset within 16 hours" .

ns2:SymptomOnset24Hours a ns1:Observation ;
    ns1:name "Symptom onset within 24 hours" .

ns2:UlceratedPlaque a ns1:Condition .

ns2:Warfarin a ns1:Medication ;
    ns1:Medication.name "Warfarin" ;
    ns1:Medication.statement "aspirin is occasionally used simultaneously with warfarin in certain high-risk patients",
        "in patients taking warfarin, antiplatelet medications additively increase risk of bleeding and are thus usually avoided" ;
    ns1:dosage "Adjusted-dose" ;
    ns1:indication ns2:NonvalvularAtrialFibrillation,
        ns2:ValvularAtrialFibrillation ;
    ns1:substance ns2:VitaminKAntagonist ;
    ns1:targetINR "2 to 3" .

ns2:AnteriorCirculation a ns1:BodyStructure ;
    ns1:name "Anterior circulation" .

ns2:AntiplateletMedications a ns1:Medication ;
    ns1:definition "Antiplatelet medications may help reduce risk of subsequent strokes" ;
    ns1:name "Antiplatelet medications" ;
    ns1:relatedTo ns2:Emboli,
        ns2:Thrombi .

ns2:BP a ns1:Observation ;
    ns1:name "Blood Pressure" ;
    ns1:relatedTo ns2:AcuteReperfusionTherapy ;
    ns1:value "< 180/105 mm Hg" .

ns2:BrainIschemia a ns1:Condition ;
    ns1:causedBy ns2:InadequateBloodFlow ;
    ns1:name "Brain ischemia" .

ns2:EfficientCollateralSystem a ns1:AnatomicalStructure ;
    ns1:name "Efficient collateral system" ;
    ns1:partOf ns2:BrainArtery .

ns2:EmbolicStrokeOfUndeterminedSource a ns1:Condition ;
    ns1:name "Embolic stroke of undetermined source" .

ns2:Headache a ns1:Symptom ;
    ns1:Symptom.description "Headache may precede neurologic deficits" ;
    ns1:name "Headache" .

ns2:HypercoagulabilityDisorders a ns1:Condition ;
    ns1:name "Hypercoagulability Disorders" ;
    ns1:relatedTo ns2:Stroke .

ns2:Hypoglycemia a ns1:Condition,
        ns1:Observation ;
    ns1:code [ a ns1:CodeableConcept ;
            ns1:coding [ a ns1:Coding ;
                    ns1:code "302866003" ;
                    ns1:display "Hypoglycemia" ;
                    ns1:system "http://snomed.info/sct" ] ] ;
    ns1:threshold "< 60 mg/dL" .

ns2:ImpairedConsciousness a ns1:Observation,
        ns1:Symptom ;
    ns1:Symptom.description "Deterioration during the first 48 to 72 hours after onset of symptoms, particularly progressively impaired consciousness" ;
    ns1:name "Impaired Consciousness" ;
    ns1:suggests ns2:PoorPrognosis .

ns2:MRI a ns1:ImagingStudy,
        ns1:Procedure ;
    ns1:code [ a ns1:CodeableConcept ;
            ns1:coding [ a ns1:Coding ;
                    ns1:code "113091000" ;
                    ns1:display "MRI" ;
                    ns1:system "http://snomed.info/sct" ] ] ;
    ns1:definition "MRI is done to exclude hemorrhage and confirm the presence and extent of stroke" ;
    ns1:partOf ns2:Neuroimaging .

ns2:NeurologicDeficits a ns1:Symptom ;
    ns1:Symptom.description "Patterns of neurologic deficits often suggest the affected artery" .

ns2:NewAnticoagulants a ns1:Medication ;
    ns1:alternativeTo ns2:Warfarin ;
    ns1:includes ns2:Apixaban,
        ns2:Dabigatran,
        ns2:Rivaroxaban .

ns2:NonvalvularAtrialFibrillation a ns1:Condition .

ns2:RareDisorders a ns1:Condition ;
    ns1:name "Rare Disorders" ;
    ns1:relatedTo ns2:Stroke .

ns2:RheumaticDisordersTesting a ns1:Procedure ;
    ns1:name "Testing for rheumatic disorders" ;
    ns1:partOf ns2:BloodTests .

ns2:SmallInfarct a ns1:Condition ;
    ns1:diagnosedBy ns2:MRI ;
    ns1:name "Small infarct" .

ns2:Tumor a ns1:Condition ;
    ns1:characteristic ns2:Bleeding,
        ns2:RapidlyGrowing,
        ns2:SuddenlySymptomatic ;
    ns1:excludedBy ns2:Neuroimaging ;
    ns1:name "Tumor" .

ns2:AnteriorCirculationIschemicStroke a ns1:Condition ;
    ns1:characteristic ns2:DenseMiddleCerebralArterySign,
        ns2:EffacementOfSulci,
        ns2:InsularCorticalRibbon,
        ns2:LossOfGrayWhiteJunction ;
    ns1:diagnosedBy ns2:CT ;
    ns1:name "Anterior circulation ischemic stroke" .

ns2:Atheromas a ns1:Condition ;
    ns1:Condition.location ns2:AorticArch,
        ns2:NeckArteries ;
    ns1:bodySite ns2:CarotidBifurcation,
        ns2:MajorCerebralArtery ;
    ns1:name "Atheromas" ;
    ns1:relatedCondition ns2:Thrombi .

ns2:CryptogenicStroke a ns1:Condition ;
    ns1:definition "No cause is identified in one-third of ischemic strokes at the time of patient discharge",
        "Stroke is classified as cryptogenic when one of the following occurs: The diagnostic evaluation is incomplete. No cause is identified despite an extensive evaluation. There is more than one probable cause (eg, atrial fibrillation and ipsilateral carotid stenosis)." ;
    ns1:hasSubcategory ns2:ESUS ;
    ns1:hasSubtype ns2:EmbolicStrokeOfUndeterminedSource ;
    ns1:name "Cryptogenic Stroke",
        "Cryptogenic stroke" .

ns2:Diabetes a ns1:Condition ;
    ns1:definition "A group of diseases that result in too much sugar in the blood (high blood glucose)." ;
    ns1:name "Diabetes" .

ns2:PoorPrognosis a ns1:Observation ;
    ns1:name "Poor Prognosis" .

ns2:SystemicPerfusionImpairment a ns1:Condition ;
    ns1:name "Systemic Perfusion Impairment" ;
    ns1:relatedTo ns2:IschemicStroke .

ns2:Vasospasm a ns1:Condition ;
    ns1:hasCause ns2:SubarachnoidHemorrhage,
        ns2:SympathomimeticDrugsUse ;
    ns1:name "Vasospasm" ;
    ns1:relatedTo ns2:IschemicStroke .

ns2:CT a ns1:ImagingStudy,
        ns1:Procedure ;
    ns1:definition "CT is done to exclude hemorrhage and confirm the presence and extent of stroke" ;
    ns1:name "CT" ;
    ns1:partOf ns2:Neuroimaging .

ns2:Hypertension a ns1:Condition ;
    ns1:Condition.property ns2:DiastolicBP,
        ns2:SystolicBP ;
    ns1:code [ a ns1:CodeableConcept ;
            ns1:coding [ a ns1:Coding ;
                    ns1:code "38341003" ;
                    ns1:display "Hypertension" ;
                    ns1:system "http://snomed.info/sct" ] ] ;
    ns1:definition "A condition in which the force of the blood against the artery walls is too high." .

ns2:HyperviscosityDisorders a ns1:Condition ;
    ns1:hasSubtype ns2:Hemoglobinopathies,
        ns2:PlasmaCellDisorders,
        ns2:Polycythemia,
        ns2:Thrombocytosis ;
    ns1:relatedTo ns2:Stroke ;
    ns1:value "Hyperviscosity Disorders" .

ns2:LacunarInfarcts a ns1:Condition ;
    ns1:Condition.symptom ns2:AtaxicHemiparesis,
        ns2:CombinedHemiparesisAndHemianesthesia,
        ns2:DysarthriaClumsyHandSyndrome,
        ns2:MultiInfarctDementia,
        ns2:PureMotorHemiparesis,
        ns2:PureSensoryHemianesthesia ;
    ns1:associatedWith ns2:Diabetes,
        ns2:Hypertension,
        ns2:Smoking ;
    ns1:causedBy ns2:Emboli,
        ns2:NonatherothromboticObstruction ;
    ns1:definition "Small (≤ 1.5 cm) infarcts resulting from nonatherothrombotic obstruction of small, perforating arteries that supply deep cortical structures." ;
    ns1:hasRiskFactor ns2:CigaretteSmoking,
        ns2:Diabetes,
        ns2:Hypertension ;
    ns1:name "Lacunar Infarcts",
        "Lacunar infarcts" ;
    ns1:relatedTo ns2:IschemicStroke .

ns2:ThromboticDisordersTesting a ns1:Procedure ;
    ns1:name "Testing for thrombotic disorders" ;
    ns1:partOf ns2:BloodTests .

ns2:VascularInflammation a ns1:Condition ;
    ns1:hasCause ns2:AcuteChronicMeningitis,
        ns2:Syphilis,
        ns2:VasculiticDisorders ;
    ns1:name "Vascular Inflammation",
        "Vascular inflammation" ;
    ns1:relatedTo ns2:Stroke .

ns2:VenousSinusThrombosis a ns1:Condition ;
    ns1:hasCause ns2:HypercoagulabilityDisorder,
        ns2:IntracranialInfection,
        ns2:PeripartumState,
        ns2:PostoperativeState ;
    ns1:name "Venous Sinus Thrombosis",
        "Venous sinus thrombosis" ;
    ns1:relatedTo ns2:IschemicStroke .

ns2:Testing a ns1:Procedure ;
    ns1:name "Testing" ;
    ns1:reasonReference ns2:VascularCauses .

ns2:CardiacCauses a ns1:Condition ;
    ns1:name "Cardiac causes" .

ns2:Emboli a ns1:Condition ;
    ns1:Condition.dislodge ns2:InvasiveCardiovascularProcedures,
        ns2:Spontaneously ;
    ns1:Condition.location ns2:CerebralArterialTree ;
    ns1:Condition.origin ns2:Air,
        ns2:Atheromas,
        ns2:CardiacThrombi,
        ns2:Clots,
        ns2:Fat,
        ns2:VenousClots ;
    ns1:code [ a ns1:CodeableConcept ;
            ns1:coding [ a ns1:Coding ;
                    ns1:code "414086009" ;
                    ns1:display "Emboli" ;
                    ns1:system "http://snomed.info/sct" ] ] ;
    ns1:definition "A blockage-causing piece of material, inside a blood vessel." .

ns2:Thrombi a ns1:Condition ;
    ns1:bodySite ns2:BasilarArtery,
        ns2:DeepPerforatingArteries,
        ns2:InternalCarotidArterySegment,
        ns2:LargeArteriesAtBaseOfBrain,
        ns2:MiddleCerebralArtery,
        ns2:SmallCorticalBranches ;
    ns1:name "Thrombi" ;
    ns1:relatedCondition ns2:Atheromas .

ns2:Neuroimaging a ns1:Procedure ;
    ns1:description "Neuroimaging" ;
    ns1:method ns2:CT,
        ns2:MRI ;
    ns1:partOf ns2:BrainAssessment .

ns2:Stroke a ns1:Condition ;
    ns1:code [ a ns1:CodeableConcept ;
            ns1:coding [ a ns1:Coding ;
                    ns1:code "230690007" ;
                    ns1:display "Stroke" ;
                    ns1:system "http://snomed.info/sct" ] ] ;
    ns1:hasSubtype ns2:Cardioembolism,
        ns2:CryptogenicStroke,
        ns2:EmbolicStrokeOfUndeterminedSource,
        ns2:IschemicStroke,
        ns2:LacunarInfarcts,
        ns2:LargeVesselAtherosclerosis ;
    ns1:outcome ns2:StrokeOutcome ;
    ns1:prognosis ns2:StrokePrognosis ;
    ns1:progression ns2:StrokeProgression ;
    ns1:purpose "reduce the risk of recurrent disabling stroke" ;
    ns1:relatedCondition ns2:Aphasia,
        ns2:BrainStemSigns,
        ns2:Hemiplegia,
        ns2:IschemicStroke ;
    ns1:severity ns2:StrokeSeverity ;
    ns1:use "acute stroke treatment" .

ns2:BloodTests a ns1:Procedure ;
    ns1:name "Blood Tests",
        "Blood tests" ;
    ns1:reasonReference ns2:BloodRelatedCauses ;
    ns1:relatedTo ns2:RheumaticDisorders,
        ns2:ThromboticDisorders .

ns2:IschemicStroke a ns1:Condition ;
    ns1:Condition.cause ns2:AtherothromboticStroke,
        ns2:CerebralEdema,
        ns2:EmbolicStroke,
        ns2:LacunarInfarcts ;
    ns1:Condition.symptom ns2:Fever,
        ns2:Headache,
        ns2:ImpairedConsciousness,
        ns2:NeurologicDeficits,
        ns2:Seizure,
        ns2:UnilateralNeurologicDysfunction ;
    ns1:categorizedAs ns2:CryptogenicStroke ;
    ns1:causedBy ns2:AtherothromboticOcclusion,
        ns2:CerebralEmbolism,
        ns2:LacunarInfarcts,
        ns2:NonthromboticOcclusion,
        ns2:ProximalArterialStenosis ;
    ns1:code [ a ns1:CodeableConcept ;
            ns1:coding [ a ns1:Coding ;
                    ns1:code "422504002" ;
                    ns1:display "Ischemic Stroke" ;
                    ns1:system "http://snomed.info/sct" ] ] ;
    ns1:component [ ns1:value "Blood",
                "Brain parenchyma",
                "Vascular system" ] ;
    ns1:definition "A type of stroke that occurs when a blood vessel supplying blood to the brain is obstructed.",
        "Sudden neurologic deficits that result from focal cerebral ischemia associated with permanent brain infarction" ;
    ns1:diagnosedBy ns2:CT,
        ns2:ClinicalDiagnosis,
        ns2:MRI ;
    ns1:hasCause ns2:AortaDissection,
        ns2:BinswangerDisease,
        ns2:CarbonMonoxideToxicity,
        ns2:Cardioembolism,
        ns2:CryptogenicStroke,
        ns2:EmbolicStrokeOfUndeterminedSource,
        ns2:FibromuscularDysplasia,
        ns2:HypercoagulabilityDisorder,
        ns2:HyperviscosityDisorders,
        ns2:Hypotension,
        ns2:Hypoxia,
        ns2:IntracranialArteriesDissection,
        ns2:LacunarInfarcts,
        ns2:LargeVesselAtherosclerosis,
        ns2:MoyamoyaDisease,
        ns2:SevereAnemia,
        ns2:SickleCellDisease,
        ns2:VascularInflammation,
        ns2:Vasospasm,
        ns2:VenousSinusThrombosis ;
    ns1:hasRiskFactor ns2:AbdominalObesity,
        ns2:CarotidArteryStenosis,
        ns2:CertainDrugsUse,
        ns2:CigaretteSmoking,
        ns2:Diabetes,
        ns2:Dyslipidemia,
        ns2:ExcessAlcoholConsumption,
        ns2:ExogenousEstrogenUse,
        ns2:FamilyHistoryOfStroke,
        ns2:HeartDisorders,
        ns2:HighRiskDiet,
        ns2:Hypercoagulability,
        ns2:Hypertension,
        ns2:InsulinResistance,
        ns2:LackOfPhysicalActivity,
        ns2:ObstructiveSleepApnea,
        ns2:OlderAge,
        ns2:PriorStroke,
        ns2:PsychosocialStress,
        ns2:RaceEthnicity,
        ns2:Sex,
        ns2:Vasculitis ;
    ns1:increasesWith ns2:Age ;
    ns1:mortalityRate "20%" ;
    ns1:relatedTo ns2:CNSInfections,
        ns2:FunctionalNeurologicDisorders,
        ns2:HemiplegicMigraine,
        ns2:PostictalParalysis,
        ns2:Stroke ;
    ns1:treatedBy ns2:Anticoagulants,
        ns2:AntiplateletMedications,
        ns2:CarotidEndarterectomy,
        ns2:Stenting,
        ns2:ThrombolyticTherapy .

